0001973062 2026-01-01 2026-03-31 0001973062 us-gaap:CommonClassAMember 2026-06-26 0001973062 us-gaap:CommonClassAMember 2026-01-01 2026-03-31 0001973062 us-gaap:CommonClassBMember 2026-06-26 0001973062 us-gaap:CommonClassBMember 2026-01-01 2026-03-31 0001973062 2026-03-31 0001973062 2025-12-31 0001973062 2025-01-01 2025-03-31 0001973062 us-gaap:PreferredStockMember 2024-12-31 0001973062 us-gaap:CommonStockMember 2024-12-31 0001973062 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001973062 us-gaap:RetainedEarningsMember 2024-12-31 0001973062 2024-12-31 0001973062 us-gaap:PreferredStockMember 2025-12-31 0001973062 us-gaap:CommonStockMember 2025-12-31 0001973062 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001973062 us-gaap:RetainedEarningsMember 2025-12-31 0001973062 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001973062 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001973062 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001973062 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001973062 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001973062 us-gaap:PreferredStockMember 2025-03-31 0001973062 us-gaap:CommonStockMember 2025-03-31 0001973062 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001973062 us-gaap:RetainedEarningsMember 2025-03-31 0001973062 2025-03-31 0001973062 us-gaap:PreferredStockMember 2026-03-31 0001973062 us-gaap:CommonStockMember 2026-03-31 0001973062 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001973062 us-gaap:RetainedEarningsMember 2026-03-31 0001973062 2025-08-31 2025-08-31 0001973062 us-gaap:SubsequentEventMember 2026-05-14 2026-05-14 0001973062 VIDA:TwoLargeCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001973062 VIDA:OneLargeCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0001973062 VIDA:OneCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001973062 VIDA:OneCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0001973062 VIDA:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001973062 VIDA:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001973062 VIDA:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001973062 2025-01-01 2025-12-31 0001973062 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001973062 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001973062 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001973062 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001973062 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001973062 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001973062 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001973062 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001973062 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2026-03-31 0001973062 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2025-12-31 0001973062 2026-06-21 0001973062 us-gaap:CommonStockMember 2025-08-31 2025-08-31 0001973062 us-gaap:PreferredStockMember 2025-08-31 2025-08-31 0001973062 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-05-14 2026-05-14 0001973062

us-gaap:PrepaidExpenseCurrentAndNoncurrent

2026-03-31 0001973062

us-gaap:PrepaidExpenseCurrentAndNoncurrent

2025-12-31 0001973062

us-gaap:AccountsPayableCurrentAndNoncurrent

2026-03-31 0001973062

us-gaap:AccountsPayableCurrentAndNoncurrent

2025-12-31 0001973062 us-gaap:SeriesAPreferredStockMember 2025-08-31 0001973062 us-gaap:SeriesAPreferredStockMember 2025-08-01 2025-08-31 0001973062 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-08-01 2025-08-31 0001973062 us-gaap:SeriesAPreferredStockMember us-gaap:CommonStockMember 2025-08-01 2025-08-31 0001973062 us-gaap:CommonStockMember 2025-11-30 0001973062 VIDA:TwoStockholdersMember us-gaap:CommonStockMember 2025-11-30 0001973062 us-gaap:CommonStockMember 2025-11-01 2025-11-30 0001973062 VIDA:SeriesSeedOnePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001973062 VIDA:SeriesSeedTwoPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001973062 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001973062 VIDA:TwoThousandTwentyTwoEquityIncentivePlanMember us-gaap:CommonStockMember 2025-11-30 0001973062 VIDA:TwoThousandTwentyTwoEquityIncentivePlanMember us-gaap:CommonStockMember 2025-12-01 0001973062 VIDA:SeriesSeedOnePreferredStockMember 2026-01-01 2026-03-31 0001973062 VIDA:SeriesSeedOnePreferredStockMember 2026-03-31 0001973062 VIDA:SeriesSeedOnePreferredStockMember 2025-12-31 0001973062 VIDA:SeriesSeedTwoPreferredStockMember 2026-03-31 0001973062 VIDA:SeriesSeedTwoPreferredStockMember 2025-12-31 0001973062 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001973062 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001973062 VIDA:SeriesAWarrantsMember 2025-08-31 0001973062 VIDA:SeriesAWarrantsMember 2025-08-01 2025-08-31 0001973062 VIDA:SeriesAWarrantsMember 2026-03-31 0001973062 VIDA:SeriesAWarrantsMember 2026-01-01 2026-03-31 0001973062 VIDA:SeriesAWarrantsMember VIDA:MeasurementInputOptionPricingModelExpectedTermMember 2026-03-31 0001973062 VIDA:SeriesAWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2026-03-31 0001973062 VIDA:SeriesAWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember 2026-03-31 0001973062 VIDA:SeriesAWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-03-31 0001973062 VIDA:SeriesAWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-03-31 0001973062 VIDA:SeriesAWarrantsMember VIDA:MeasurementInputPathsMonthlyTimeStepsMember 2026-03-31 0001973062 VIDA:TwoThousandTwentyTwoEquityIncentivePlanMember us-gaap:CommonStockMember 2026-03-31 0001973062 VIDA:TwoThousandTwentyTwoEquityIncentivePlanMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-04-01 0001973062 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001973062 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001973062 us-gaap:EmployeeStockOptionMember 2026-03-31 0001973062 us-gaap:RestrictedStockMember 2026-01-01 2026-03-31 0001973062 us-gaap:RestrictedStockMember 2026-03-31 0001973062 us-gaap:RestrictedStockMember 2025-01-01 2025-03-31 0001973062 2024-01-01 2024-12-31 0001973062 VIDA:SeriesSeedTwoPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001973062 VIDA:SeriesSeedOnePreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001973062 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001973062 VIDA:SeriesSeedTwoPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001973062 VIDA:SeriesSeedOnePreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001973062 VIDA:ThreeSoftwareAgreementsMember 2026-03-31 0001973062 VIDA:EmployeeCompensationAndBenefitsMember 2026-01-01 2026-03-31 0001973062 VIDA:EmployeeCompensationAndBenefitsMember 2025-01-01 2025-03-31 0001973062 us-gaap:StockCompensationPlanMember 2026-01-01 2026-03-31 0001973062 us-gaap:StockCompensationPlanMember 2025-01-01 2025-03-31 0001973062 VIDA:OtherMember 2026-01-01 2026-03-31 0001973062 VIDA:OtherMember 2025-01-01 2025-03-31 0001973062 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-05-18 2026-05-18 0001973062 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-05-18 0001973062 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-05-27 2026-05-27 0001973062 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-05-27 0001973062 us-gaap:SubsequentEventMember us-gaap:IPOMember 2026-05-18 2026-05-18 0001973062 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:IPOMember VIDA:BenchmarkCompanyLLCMember 2026-05-18 0001973062 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:IPOMember VIDA:BenchmarkCompanyLLCMember 2026-05-27 0001973062 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-11-14 0001973062 VIDA:EmployeeMember us-gaap:StockOptionMember us-gaap:SubsequentEventMember 2026-09-19 0001973062 VIDA:EmployeeMember us-gaap:StockOptionMember us-gaap:SubsequentEventMember 2026-09-19 2026-09-19 iso4217:USD shares iso4217:USD shares pure false --12-31 Q1 0001973062

10-Q true 2026-03-31 2026 false 001-43282 VIDA GLOBAL INC. DE 88-1438776 12160 W Parmer Ln Ste 130-716 Cedar Park TX 78613 (833) 588-8432 Class A Common Stock, par value $0.001 per share VIDA NYSEAMER No Yes Non-accelerated Filer true true false false 9156530 0.001 5426402 0.001

1358556

2317761

76038

101667

23073 11990

641088

321437

2098755

2752855

797950 1023306

2403209

2362313

5919

6511

1454

5307287

6146439

316147

184349

2368

77207 107807

28542

29440

424264

321596

424264

321596

0.001

1318836

1242635

1243

0.001

13969410

6084208

5426400

6083

5426

10574786

10405019

-5699089

-4586845

4883023

5824843

5307287

6146439

306032

35663

146487 75859

184148

121197

231172

110712

631113

134590

1192920

442358

-886888

-406695

-225356 -115338

-225356

-115338

-1112244

-522033

4429508

3203331

-0.25

-0.16

631336

632

5426400

5426

5269320

-1689042

3586336

121381

-522033

631336

632

5426400

5426

5390701

-2211075

3185684

1242635

1243

5426400

5426

10405019

-4586845

5824843

170424

657808

657

-657

-1112244

1242635

1243

6084208

6083

10574786

-5699089

4883023

-1112244

-522033

184148

121197

-225356 -115338

1811

109487 52881 17872 1715

-25629

-16629

11083

236801

-7506

18348 5408

2368

-898

7324

-1811

-777818

-194035

181387

118292

-181387

-118292

-959205

-312327

2317761

724296

1358556

411969

43065 66785 82850

1. Nature of Operations VIDA Global Inc. (the “Company”) was incorporated in Delaware in 2022 and is headquartered in Cedar Park, Texas. The Company is a software as a service (“SaaS”) provider delivering a cloud-based AI agent operating system that enables enterprises, service providers, and resellers to build, deploy, and manage omnichannel AI agents that handle voice calls, text messages, emails, and web chat while automating business workflows at scale. These AI agents are used by telecom providers, managed service providers, and small and medium sized businesses across a range of industries to automate customer service, lead qualification, scheduling, sales, and other customer engagement tasks. The Company operates as a single operating segment and a single reportable segment based on how its chief operating decision maker (“CODM”) reviews financial information and manages the business. Substantially all of the Company’s long-lived assets are located in the United States, and substantially all of the Company’s revenue is derived from customers located in the United States.

2. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and presented in U.S. dollars under the accrual basis of accounting. The Company’s condensed financial statements are prepared in accordance with the U.S. Securities and Exchange Commission’s (“SEC”) rules for the presentation of interim financial statements, which permit certain disclosures to be condensed or omitted. These condensed financial statements should be read in conjunction with the Company’s annual financial statements as of and for the year ended December 31, 2025 included in the Company’s final prospectus dated May 14, 2026, filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on May 18, 2026. In the opinion of management, the accompanying interim condensed financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company’s financial position as of March 31, 2026, and its results of operations and cash flows for the three months ended March 31, 2026 and 2025. Operating results for the three months ended March 31, 2026 and 2025, are not necessarily indicative of the results that may be expected for the years ending December 31, 2026 and 2025. Use of Estimates The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions affecting the amounts reported and disclosed in the accompanying condensed financial statements and related footnotes, including fair value measurement of stock-based compensation, capitalized software costs including useful lives, impairment, and recoverability, and realizability of deferred tax assets. Actual results could differ from those estimates. Due to the early stage of the Company’s operations and the rapidly evolving nature of its industry, it is at least reasonably possible that estimates made in preparing these condensed financial statements could change in the near term as new events occur, additional information becomes available or the Company’s operating environment changes. Such changes in estimates could be material to these condensed financial statements. Revenue Recognition Under Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, the Company recognizes revenue when control of the promised services is transferred to customers, in an amount that reflects the consideration expected in exchange for those services. Revenue is derived from SaaS subscriptions with fixed monthly billing terms, plus usage fees when customers exceed usage tiers. Substantially all of the Company’s revenue is derived from subscription arrangements that provide customers with access to the Company’s cloud-based platform on a stand-ready basis over the contract term, which is typically one month. The Company’s performance obligation is satisfied over time as the customer simultaneously receives and consumes the benefits provided by the Company’s services. The Company’s contracts generally renew automatically on a monthly basis and are cancellable by the customer with minimal notice. Consideration is typically billed in advance on a monthly basis based on the contracted subscription plan, with additional usage-based consideration billed monthly in arrears when customers exceed their contracted usage tiers. For the majority of the Company’s customers, amounts billed are collected immediately via credit card through a third-party payment processor. Starting in 2025, select customers were extended payment terms of 30 days. The Company has concluded that its contracts do not contain a significant financing component because the period between transfer of services and customer payment is generally one year or less. The Company allocates the transaction price to the single performance obligation in the contract, which is access to the hosted platform, and recognizes revenue on a straight-line basis over the monthly service period. Variable consideration related to usage fees is recognized in the distinct monthly contract period the usage fees are incurred and the services are transferred utilizing the variable consideration allocation exception. Due to the timing of billing and use of the variable consideration allocation exception, variable consideration is not constrained. Substantially all revenue is derived from a single revenue stream consisting of subscription and related usage-based fees from the Company’s cloud-based platform. Management, therefore, believes that the level of disaggregation presented in the condensed statements of operations appropriately depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Cost of Revenue Cost of revenue consists primarily of software and related technology expenses incurred to operate, maintain, and support the Company’s software platform that is delivered to customers. These costs generally include third-party software licenses, hosting and cloud infrastructure fees, data and network services, and other technology costs directly associated with providing access to the Company’s platform. Cost of revenue excludes expenses that are subject to capitalization, including internal and external costs incurred to develop or significantly enhance the underlying software platform or other capitalizable technology assets. Such capitalizable costs are recorded as capitalized software costs and are amortized to expense over their estimated useful lives, which is presented separately as a component of operating expenses on the condensed statements of operations. Cost of revenue also excludes general and administrative expenses, sales and marketing expenses, and other overhead costs that are not directly attributable to delivering the Company’s software platform to customers. Effect of Stock Splits On August 31, 2025, the Company effected a 2-for-1 stock split (the “August 2025 Stock Split”) of its common stock and preferred stock. In addition, in connection with the Company’s initial public offering (“IPO”) which closed on May 18, 2026, the Company effected a 3.57-for-1 stock split (the “May 2026 Stock Split”) of the Company’s common stock on May 14, 2026, the effective date of the registration statement used in connection with the IPO. No fractional shares were issued in connection with the stock splits. In lieu of fractional shares, any person who would otherwise be entitled to a fractional share of preferred or common stock as a result of the stock splits instead received a number of shares rounded up to the nearest whole share. Proportional adjustments were made to the number of shares of common stock issuable upon exercise or conversion of the Company’s outstanding equity awards and warrants, as well as the applicable exercise price, except in cases where the applicable agreement provides otherwise. All share and per share amounts in the accompanying condensed financial statements have been retroactively adjusted to reflect the August 2025 Stock Split and the May 2026 Stock Split for all periods presented. Contract Balances Contract Liabilities (Deferred Revenue) The Company records deferred revenue for amounts billed but not yet earned. Amounts are typically earned in the following month due to the Company’s monthly contract terms and billing practices. The table below presents a roll forward of contract liabilities (deferred revenue) for the three months ended March 31, 2026 and 2025. All revenue associated with deferred revenue as of March 31, 2026 is expected to be recognized within one year and is therefore classified as current liability on the accompanying condensed balance sheet. Schedule of Current Liability <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zlcggQDIk2Db" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20250101__20250331_zLgeCPRPvYpd" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_zdQ50THJGuF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">29,440</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,730</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--RecognitionOfDeferredRevenues_ztV550CrpY3g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenue recognized</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(184,324</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(34,275</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--DeferredRevenueBillings_zkCQB61Pflw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Billings</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">183,426</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">41,599</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ContractWithCustomerLiabilityCurrent_iE_zm5ZaLCIBqDj" style="vertical-align: bottom; background-color: White"> <td>Ending balance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">28,542</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,054</td><td style="text-align: left"> </td></tr> </table> Contract Assets The Company’s contract assets consist entirely of unbilled usage fees that arise when customers exceed their contracted usage tiers during the month but have not yet been invoiced. Such amounts are billed to customers in the month following the period in which the usage is incurred and are classified within current assets on the accompanying condensed balance sheets. As of March 31, 2026 and December 31, 2025, the contract asset balance was $23,073 and $11,990, respectively, representing usage fees earned but not yet invoiced as of those dates. As of March 31, 2025 and December 31, 2024, the Company did not have any contract assets from usage fees earned but not yet invoiced. Accounts Receivable Accounts receivable is recorded at the invoiced amount and represents uncollateralized amounts due from customers under customary trade credit terms. The Company receives payments from customers through a third-party payment processor and as a result records a receivable balance within accounts receivable from the third-party payment processor. As of March 31, 2026 and December 31, 2025, the Company’s accounts receivable balance included $17,942 and $4,508, respectively, due from the third-party payment processor. At March 31, 2026 and December 31, 2025, the accounts receivable balance also consisted of amounts owed by a limited number of customers under 30 day payment terms. At March 31, 2026 and December 31, 2025, the accounts receivable balance was $76,038 and $101,667, respectively. At March 31, 2025 and December 31, 2024, the accounts receivable balance was $3,211 and $19,840, respectively. Allowance for Credit Losses The carrying amount of accounts receivable and contract assets are recorded net of an allowance for credit losses, if any. The Company estimates expected credit losses on its accounts receivable and contract assets using the current expected credit loss model based on factors such as historical loss experience, the aging of receivables, the credit quality of its customers, current economic conditions and other applicable factors. In addition, the Company assumes that current conditions as of the balance sheet date will not change over the remaining life of the asset. Balances are written off when management determines that collection is not probable. Recoveries of amounts previously written off are recorded when received. The Company did not record an allowance for credit losses for accounts receivable or contract assets as of March 31, 2026 or December 31, 2025 because expected credit losses were not material based on the Company’s limited loss history and the credit quality of its customers. In addition, no credit loss expense or recoveries income was recognized during the three months ended March 31, 2026 and 2025. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, bitcoin, and accounts receivable. Cash is maintained with high quality financial institutions and, at times, such balances may exceed federally insured limits. The Company has not experienced any losses on such accounts, and management believes the Company is not exposed to significant credit risk on its cash balances. As of March 31, 2026 and December 31, 2025, balances held as Cash at these financial institutions were $1,358,556 and $2,317,761 respectively. As of March 31, 2026 and December 31, 2025, the majority of the Company’s bitcoin holdings were held by a third party custodian. The holdings are not insured by the Federal Deposit Insurance Company (FDIC) or protected by the Securities Investor Protection Corporation (SIPC). The concentration of bitcoin holdings limits the risk mitigation that could be achieved if the Company were to purchase a more diversified portfolio of investments. The Company’s strategy of acquiring and holding bitcoin creates exposure to counterparty risks with respect to the custody of its bitcoin, cybersecurity risks, and other risks inherent to holding a digital asset. The Company is relying on the custodian’s internal controls and compliance with SOC 2 Type 2 standards. A disruption in the operations or a breach of security at the custodian could have a material adverse effect on the Company’s financial position. Additionally, the price of bitcoin has historically experienced significant price volatility, and a significant decline in the fair value of bitcoin would adversely affect the Company’s financial condition and results of operations. At March 31, 2026, concentration of credit risk with respect to accounts receivable was primarily from two larger customers accounting for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--TwoLargeCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z6aEqXjh8OG9" title="Concentration risk percentage">64% of the balance. No other customer balance was over 10% of the total accounts receivable balance. At December 31, 2025, concentration of credit risk with respect to accounts receivable was primarily from one large customer accounting for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20250101__20251231__srt--MajorCustomersAxis__custom--OneLargeCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zUZjxSJTI5Wh" title="Concentration risk percentage">65% of the balance. No other customer balance was over 10% of the total accounts receivable balance. At March 31, 2026, concentration of credit risk with respect to the unbilled usage contract assets was from one customer accounting for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zps2NO19fY7e" title="Concentration risk percentage">77% of the unbilled usage contract asset. No other customer was over 10% of the unbilled usage balance. At December 31, 2025, concentration of credit risk with respect to the unbilled usage contract assets was from one customer accounting for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20250101__20251231__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zzwMPoFtWFKk" title="Concentration risk percentage">73% of the unbilled usage contract asset. No other customer was over 10% of the unbilled usage balance. The Company also has concentration risk related to its revenues. For the three months ended March 31, 2026, two customers accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zZpONOF1gWn" title="Concentration risk percentage">43% of revenue, with one customer representing approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zW2KJ4U5qYia" title="Concentration risk percentage">33% of revenue while the other represents approximately 10% of revenue. For the three months ended March 31, 2025, one customer accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20250101__20250331__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYqspP75n91l" title="Concentration risk percentage">20% of revenue. While the Company continues to pursue diversification of its customer base, the loss of, or significant reduction in business from, either of these major customers could have a material adverse effect on the Company’s financial condition, results of operations, and cash flows. Advertising Costs Advertising costs are expensed as incurred and are included in sales and marketing expense in the condensed statements of operations. Advertising expenses were $81,936 and $37,843 for the three months ended March 31, 2026 and 2025, respectively. Long-Lived Assets and Impairment The Company evaluates long-lived assets, which consist primarily of capitalized software costs, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Indicators of impairment may include a significant decline in the observable market value of an asset, a significant change in the extent or manner in which an asset is used or its physical condition, a significant adverse change in legal factors or in the business climate, or current period operating or cash flow losses combined with a history of such losses or projections of continuing losses. Recoverability of long-lived assets is assessed by comparing the carrying amount of the asset group to the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset group. If the carrying amount exceeds the undiscounted cash flows, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the asset’s fair value. Fair value is generally determined using discounted cash flow models or other valuation techniques. Based on operating losses and negative cash flows from operations as of March 31, 2026 and December 31, 2025, management evaluated the carrying amount of the capitalized software costs for impairment and determined that none was necessary based on the following factors: (1) Continued usage and development of the Company’s single software platform. (2) Increased revenues experienced in 2025 and to date in 2026 as well as additional increases expected in future periods based on executed customer contracts and forecasted sales. As such, the Company did not recognize any impairment charges on long-lived assets for the three months ended March 31, 2026 or 2025. Bitcoin and Digital Assets The Company holds bitcoin as part of its treasury strategy. Bitcoin is accounted for as a digital asset and is presented separately within long-term assets on the accompanying condensed balance sheets. The Company measures its bitcoin holdings at fair value on a recurring basis using quoted prices in active markets (Level 1 within the fair value hierarchy). See Note 4 for more information. Changes in the fair value of bitcoin, including both realized gains and losses on sale and unrealized gains and losses arising from remeasurement, are recorded in other income (expense) in the condensed statements of operations. Transaction costs incurred to acquire bitcoin are expensed as incurred. The Company does not hold digital assets on behalf of customers. The Company uses the First-in, First-out (FIFO) method as its standard cost basis method for its bitcoin for accounting and reporting purposes. Under the FIFO method, the earliest bitcoin acquired are treated as the first ones sold or used, so the oldest cost layers are utilized first when calculating cost basis and gains and losses resulting from the sale or disposal of bitcoin assets. Income Taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting bases and the tax bases of assets and liabilities, as well as for net operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established if it is more likely than not that some or all of the deferred tax assets will not be realized. In making this assessment, the Company evaluates all available positive and negative evidence, including historical operating results, forecasts of future taxable income, reversal of existing temporary differences, and tax planning strategies. The Company has incurred net operating losses since inception and has recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of an income tax position only if it is more likely than not that the position will be sustained upon examination based on the technical merits of the position. Unrecognized tax benefits, if any, are recorded as a liability and adjusted in the period in which new information becomes available. Interest and penalties related to uncertain tax positions, if any, are recognized as a component of income tax expense in the condensed statements of operations. The Company’s income tax returns remain subject to examination by tax authorities for all periods since inception. The Company had no income taxes paid during the three months ended March 31, 2026. Additionally, the Company did not recognize any income tax expense during the three months ended March 31, 2026, due to the Company’s net losses incurred during the period. Further, as of March 31, 2026, the Company did not have any deferred tax assets or deferred tax liabilities due to its full valuation allowance. The Company had no income taxes paid during the three months ended March 31, 2025. Additionally, the Company did not recognize any income tax expense during the three months ended March 31, 2025, due to the Company’s net losses incurred during the period. Further, as of December 31, 2025, the Company did not have any deferred tax assets or deferred tax liabilities due to its full valuation allowance. Recently Issued Accounting Pronouncements In 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income (Topic 220): Disaggregation of Income Statement Expenses, which requires public business entities to disaggregate specified expense captions (such as certain inventory-related costs and employee compensation) in the notes, using either a cost-incurred or expense-incurred basis, to provide greater transparency into the components of operating expenses. The amendments are effective for public business entities for annual periods beginning after December 15, 2026 (with interim period requirements beginning thereafter) and allows prospective or retrospective adoption with early adoption permitted. The Company has not early adopted ASU 2024-03 and is evaluating the impact of the guidance but does not expect adoption to have a material effect on its financial position or results of operations; however, the Company expects additional disaggregation disclosures of certain income statement expense captions in the notes to the financial statements. In 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The ASU modernizes the accounting for internal-use software costs to reflect the evolution of current software development practices, including the widespread use of incremental and iterative development approaches such as agile. Under previous guidance, internal-use software costs were capitalized based on prescribed, sequential “project stages” (preliminary, application development, and post-implementation). The new ASU eliminates all references to project stages and instead requires entities to begin capitalizing internal-use software costs only when (i) management has authorized and committed to funding the project and (ii) it is probable the project will be completed and the software will be used as intended (the “probable-to-complete” recognition threshold). The ASU also supersedes existing website development guidance in Subtopic 350-50 and incorporates applicable website-related recognition and cost guidance directly into Subtopic 350-40. ASU 2025-06 is effective for public business entities beginning after December 15, 2027, with early adoption permitted. Entities may adopt the guidance on a prospective, modified retrospective, or full retrospective basis. The Company has not early adopted ASU 2025-06 and is evaluating the impact of the guidance but does not expect adoption to materially change the nature of costs eligible for capitalization or the point at which software is considered substantially complete and ready for its intended use. The Company has evaluated other recently issued accounting pronouncements and does not expect any such standards to have a material impact on its financial position, results of operations, or cash flows.

Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and presented in U.S. dollars under the accrual basis of accounting. The Company’s condensed financial statements are prepared in accordance with the U.S. Securities and Exchange Commission’s (“SEC”) rules for the presentation of interim financial statements, which permit certain disclosures to be condensed or omitted. These condensed financial statements should be read in conjunction with the Company’s annual financial statements as of and for the year ended December 31, 2025 included in the Company’s final prospectus dated May 14, 2026, filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on May 18, 2026. In the opinion of management, the accompanying interim condensed financial statements include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company’s financial position as of March 31, 2026, and its results of operations and cash flows for the three months ended March 31, 2026 and 2025. Operating results for the three months ended March 31, 2026 and 2025, are not necessarily indicative of the results that may be expected for the years ending December 31, 2026 and 2025.

Use of Estimates The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions affecting the amounts reported and disclosed in the accompanying condensed financial statements and related footnotes, including fair value measurement of stock-based compensation, capitalized software costs including useful lives, impairment, and recoverability, and realizability of deferred tax assets. Actual results could differ from those estimates. Due to the early stage of the Company’s operations and the rapidly evolving nature of its industry, it is at least reasonably possible that estimates made in preparing these condensed financial statements could change in the near term as new events occur, additional information becomes available or the Company’s operating environment changes. Such changes in estimates could be material to these condensed financial statements.

Revenue Recognition Under Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, the Company recognizes revenue when control of the promised services is transferred to customers, in an amount that reflects the consideration expected in exchange for those services. Revenue is derived from SaaS subscriptions with fixed monthly billing terms, plus usage fees when customers exceed usage tiers. Substantially all of the Company’s revenue is derived from subscription arrangements that provide customers with access to the Company’s cloud-based platform on a stand-ready basis over the contract term, which is typically one month. The Company’s performance obligation is satisfied over time as the customer simultaneously receives and consumes the benefits provided by the Company’s services. The Company’s contracts generally renew automatically on a monthly basis and are cancellable by the customer with minimal notice. Consideration is typically billed in advance on a monthly basis based on the contracted subscription plan, with additional usage-based consideration billed monthly in arrears when customers exceed their contracted usage tiers. For the majority of the Company’s customers, amounts billed are collected immediately via credit card through a third-party payment processor. Starting in 2025, select customers were extended payment terms of 30 days. The Company has concluded that its contracts do not contain a significant financing component because the period between transfer of services and customer payment is generally one year or less. The Company allocates the transaction price to the single performance obligation in the contract, which is access to the hosted platform, and recognizes revenue on a straight-line basis over the monthly service period. Variable consideration related to usage fees is recognized in the distinct monthly contract period the usage fees are incurred and the services are transferred utilizing the variable consideration allocation exception. Due to the timing of billing and use of the variable consideration allocation exception, variable consideration is not constrained. Substantially all revenue is derived from a single revenue stream consisting of subscription and related usage-based fees from the Company’s cloud-based platform. Management, therefore, believes that the level of disaggregation presented in the condensed statements of operations appropriately depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

Cost of Revenue Cost of revenue consists primarily of software and related technology expenses incurred to operate, maintain, and support the Company’s software platform that is delivered to customers. These costs generally include third-party software licenses, hosting and cloud infrastructure fees, data and network services, and other technology costs directly associated with providing access to the Company’s platform. Cost of revenue excludes expenses that are subject to capitalization, including internal and external costs incurred to develop or significantly enhance the underlying software platform or other capitalizable technology assets. Such capitalizable costs are recorded as capitalized software costs and are amortized to expense over their estimated useful lives, which is presented separately as a component of operating expenses on the condensed statements of operations. Cost of revenue also excludes general and administrative expenses, sales and marketing expenses, and other overhead costs that are not directly attributable to delivering the Company’s software platform to customers. Effect of Stock Splits On August 31, 2025, the Company effected a 2-for-1 stock split (the “August 2025 Stock Split”) of its common stock and preferred stock. In addition, in connection with the Company’s initial public offering (“IPO”) which closed on May 18, 2026, the Company effected a 3.57-for-1 stock split (the “May 2026 Stock Split”) of the Company’s common stock on May 14, 2026, the effective date of the registration statement used in connection with the IPO. No fractional shares were issued in connection with the stock splits. In lieu of fractional shares, any person who would otherwise be entitled to a fractional share of preferred or common stock as a result of the stock splits instead received a number of shares rounded up to the nearest whole share. Proportional adjustments were made to the number of shares of common stock issuable upon exercise or conversion of the Company’s outstanding equity awards and warrants, as well as the applicable exercise price, except in cases where the applicable agreement provides otherwise. All share and per share amounts in the accompanying condensed financial statements have been retroactively adjusted to reflect the August 2025 Stock Split and the May 2026 Stock Split for all periods presented.

2-for-1

3.57-for-1

Contract Balances Contract Liabilities (Deferred Revenue) The Company records deferred revenue for amounts billed but not yet earned. Amounts are typically earned in the following month due to the Company’s monthly contract terms and billing practices. The table below presents a roll forward of contract liabilities (deferred revenue) for the three months ended March 31, 2026 and 2025. All revenue associated with deferred revenue as of March 31, 2026 is expected to be recognized within one year and is therefore classified as current liability on the accompanying condensed balance sheet. Schedule of Current Liability <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zlcggQDIk2Db" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20250101__20250331_zLgeCPRPvYpd" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_zdQ50THJGuF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">29,440</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,730</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--RecognitionOfDeferredRevenues_ztV550CrpY3g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenue recognized</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(184,324</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(34,275</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--DeferredRevenueBillings_zkCQB61Pflw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Billings</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">183,426</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">41,599</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ContractWithCustomerLiabilityCurrent_iE_zm5ZaLCIBqDj" style="vertical-align: bottom; background-color: White"> <td>Ending balance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">28,542</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,054</td><td style="text-align: left"> </td></tr> </table> Contract Assets The Company’s contract assets consist entirely of unbilled usage fees that arise when customers exceed their contracted usage tiers during the month but have not yet been invoiced. Such amounts are billed to customers in the month following the period in which the usage is incurred and are classified within current assets on the accompanying condensed balance sheets. As of March 31, 2026 and December 31, 2025, the contract asset balance was $23,073 and $11,990, respectively, representing usage fees earned but not yet invoiced as of those dates. As of March 31, 2025 and December 31, 2024, the Company did not have any contract assets from usage fees earned but not yet invoiced.

Schedule of Current Liability <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zlcggQDIk2Db" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20250101__20250331_zLgeCPRPvYpd" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_zdQ50THJGuF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">29,440</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,730</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--RecognitionOfDeferredRevenues_ztV550CrpY3g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenue recognized</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(184,324</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(34,275</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--DeferredRevenueBillings_zkCQB61Pflw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Billings</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">183,426</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">41,599</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ContractWithCustomerLiabilityCurrent_iE_zm5ZaLCIBqDj" style="vertical-align: bottom; background-color: White"> <td>Ending balance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">28,542</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,054</td><td style="text-align: left"> </td></tr> </table>

29440

1730

-184324 -34275 183426 41599

28542

9054

23073 11990

Accounts Receivable Accounts receivable is recorded at the invoiced amount and represents uncollateralized amounts due from customers under customary trade credit terms. The Company receives payments from customers through a third-party payment processor and as a result records a receivable balance within accounts receivable from the third-party payment processor. As of March 31, 2026 and December 31, 2025, the Company’s accounts receivable balance included $17,942 and $4,508, respectively, due from the third-party payment processor. At March 31, 2026 and December 31, 2025, the accounts receivable balance also consisted of amounts owed by a limited number of customers under 30 day payment terms. At March 31, 2026 and December 31, 2025, the accounts receivable balance was $76,038 and $101,667, respectively. At March 31, 2025 and December 31, 2024, the accounts receivable balance was $3,211 and $19,840, respectively.

17942

4508

76038

101667

3211

19840

Allowance for Credit Losses The carrying amount of accounts receivable and contract assets are recorded net of an allowance for credit losses, if any. The Company estimates expected credit losses on its accounts receivable and contract assets using the current expected credit loss model based on factors such as historical loss experience, the aging of receivables, the credit quality of its customers, current economic conditions and other applicable factors. In addition, the Company assumes that current conditions as of the balance sheet date will not change over the remaining life of the asset. Balances are written off when management determines that collection is not probable. Recoveries of amounts previously written off are recorded when received. The Company did not record an allowance for credit losses for accounts receivable or contract assets as of March 31, 2026 or December 31, 2025 because expected credit losses were not material based on the Company’s limited loss history and the credit quality of its customers. In addition, no credit loss expense or recoveries income was recognized during the three months ended March 31, 2026 and 2025.

Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, bitcoin, and accounts receivable. Cash is maintained with high quality financial institutions and, at times, such balances may exceed federally insured limits. The Company has not experienced any losses on such accounts, and management believes the Company is not exposed to significant credit risk on its cash balances. As of March 31, 2026 and December 31, 2025, balances held as Cash at these financial institutions were $1,358,556 and $2,317,761 respectively. As of March 31, 2026 and December 31, 2025, the majority of the Company’s bitcoin holdings were held by a third party custodian. The holdings are not insured by the Federal Deposit Insurance Company (FDIC) or protected by the Securities Investor Protection Corporation (SIPC). The concentration of bitcoin holdings limits the risk mitigation that could be achieved if the Company were to purchase a more diversified portfolio of investments. The Company’s strategy of acquiring and holding bitcoin creates exposure to counterparty risks with respect to the custody of its bitcoin, cybersecurity risks, and other risks inherent to holding a digital asset. The Company is relying on the custodian’s internal controls and compliance with SOC 2 Type 2 standards. A disruption in the operations or a breach of security at the custodian could have a material adverse effect on the Company’s financial position. Additionally, the price of bitcoin has historically experienced significant price volatility, and a significant decline in the fair value of bitcoin would adversely affect the Company’s financial condition and results of operations. At March 31, 2026, concentration of credit risk with respect to accounts receivable was primarily from two larger customers accounting for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--TwoLargeCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z6aEqXjh8OG9" title="Concentration risk percentage">64% of the balance. No other customer balance was over 10% of the total accounts receivable balance. At December 31, 2025, concentration of credit risk with respect to accounts receivable was primarily from one large customer accounting for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20250101__20251231__srt--MajorCustomersAxis__custom--OneLargeCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zUZjxSJTI5Wh" title="Concentration risk percentage">65% of the balance. No other customer balance was over 10% of the total accounts receivable balance. At March 31, 2026, concentration of credit risk with respect to the unbilled usage contract assets was from one customer accounting for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zps2NO19fY7e" title="Concentration risk percentage">77% of the unbilled usage contract asset. No other customer was over 10% of the unbilled usage balance. At December 31, 2025, concentration of credit risk with respect to the unbilled usage contract assets was from one customer accounting for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20250101__20251231__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zzwMPoFtWFKk" title="Concentration risk percentage">73% of the unbilled usage contract asset. No other customer was over 10% of the unbilled usage balance. The Company also has concentration risk related to its revenues. For the three months ended March 31, 2026, two customers accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zZpONOF1gWn" title="Concentration risk percentage">43% of revenue, with one customer representing approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20260101__20260331__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zW2KJ4U5qYia" title="Concentration risk percentage">33% of revenue while the other represents approximately 10% of revenue. For the three months ended March 31, 2025, one customer accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20250101__20250331__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYqspP75n91l" title="Concentration risk percentage">20% of revenue. While the Company continues to pursue diversification of its customer base, the loss of, or significant reduction in business from, either of these major customers could have a material adverse effect on the Company’s financial condition, results of operations, and cash flows.

1358556

2317761

0.64

0.65

0.77

0.73

0.43

0.33

0.20

Advertising Costs Advertising costs are expensed as incurred and are included in sales and marketing expense in the condensed statements of operations. Advertising expenses were $81,936 and $37,843 for the three months ended March 31, 2026 and 2025, respectively.

81936

37843

Long-Lived Assets and Impairment The Company evaluates long-lived assets, which consist primarily of capitalized software costs, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Indicators of impairment may include a significant decline in the observable market value of an asset, a significant change in the extent or manner in which an asset is used or its physical condition, a significant adverse change in legal factors or in the business climate, or current period operating or cash flow losses combined with a history of such losses or projections of continuing losses. Recoverability of long-lived assets is assessed by comparing the carrying amount of the asset group to the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset group. If the carrying amount exceeds the undiscounted cash flows, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the asset’s fair value. Fair value is generally determined using discounted cash flow models or other valuation techniques. Based on operating losses and negative cash flows from operations as of March 31, 2026 and December 31, 2025, management evaluated the carrying amount of the capitalized software costs for impairment and determined that none was necessary based on the following factors: (1) Continued usage and development of the Company’s single software platform. (2) Increased revenues experienced in 2025 and to date in 2026 as well as additional increases expected in future periods based on executed customer contracts and forecasted sales. As such, the Company did not recognize any impairment charges on long-lived assets for the three months ended March 31, 2026 or 2025.

Bitcoin and Digital Assets The Company holds bitcoin as part of its treasury strategy. Bitcoin is accounted for as a digital asset and is presented separately within long-term assets on the accompanying condensed balance sheets. The Company measures its bitcoin holdings at fair value on a recurring basis using quoted prices in active markets (Level 1 within the fair value hierarchy). See Note 4 for more information. Changes in the fair value of bitcoin, including both realized gains and losses on sale and unrealized gains and losses arising from remeasurement, are recorded in other income (expense) in the condensed statements of operations. Transaction costs incurred to acquire bitcoin are expensed as incurred. The Company does not hold digital assets on behalf of customers. The Company uses the First-in, First-out (FIFO) method as its standard cost basis method for its bitcoin for accounting and reporting purposes. Under the FIFO method, the earliest bitcoin acquired are treated as the first ones sold or used, so the oldest cost layers are utilized first when calculating cost basis and gains and losses resulting from the sale or disposal of bitcoin assets.

Income Taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting bases and the tax bases of assets and liabilities, as well as for net operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established if it is more likely than not that some or all of the deferred tax assets will not be realized. In making this assessment, the Company evaluates all available positive and negative evidence, including historical operating results, forecasts of future taxable income, reversal of existing temporary differences, and tax planning strategies. The Company has incurred net operating losses since inception and has recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of an income tax position only if it is more likely than not that the position will be sustained upon examination based on the technical merits of the position. Unrecognized tax benefits, if any, are recorded as a liability and adjusted in the period in which new information becomes available. Interest and penalties related to uncertain tax positions, if any, are recognized as a component of income tax expense in the condensed statements of operations. The Company’s income tax returns remain subject to examination by tax authorities for all periods since inception. The Company had no income taxes paid during the three months ended March 31, 2026. Additionally, the Company did not recognize any income tax expense during the three months ended March 31, 2026, due to the Company’s net losses incurred during the period. Further, as of March 31, 2026, the Company did not have any deferred tax assets or deferred tax liabilities due to its full valuation allowance. The Company had no income taxes paid during the three months ended March 31, 2025. Additionally, the Company did not recognize any income tax expense during the three months ended March 31, 2025, due to the Company’s net losses incurred during the period. Further, as of December 31, 2025, the Company did not have any deferred tax assets or deferred tax liabilities due to its full valuation allowance.

Recently Issued Accounting Pronouncements In 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income (Topic 220): Disaggregation of Income Statement Expenses, which requires public business entities to disaggregate specified expense captions (such as certain inventory-related costs and employee compensation) in the notes, using either a cost-incurred or expense-incurred basis, to provide greater transparency into the components of operating expenses. The amendments are effective for public business entities for annual periods beginning after December 15, 2026 (with interim period requirements beginning thereafter) and allows prospective or retrospective adoption with early adoption permitted. The Company has not early adopted ASU 2024-03 and is evaluating the impact of the guidance but does not expect adoption to have a material effect on its financial position or results of operations; however, the Company expects additional disaggregation disclosures of certain income statement expense captions in the notes to the financial statements. In 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The ASU modernizes the accounting for internal-use software costs to reflect the evolution of current software development practices, including the widespread use of incremental and iterative development approaches such as agile. Under previous guidance, internal-use software costs were capitalized based on prescribed, sequential “project stages” (preliminary, application development, and post-implementation). The new ASU eliminates all references to project stages and instead requires entities to begin capitalizing internal-use software costs only when (i) management has authorized and committed to funding the project and (ii) it is probable the project will be completed and the software will be used as intended (the “probable-to-complete” recognition threshold). The ASU also supersedes existing website development guidance in Subtopic 350-50 and incorporates applicable website-related recognition and cost guidance directly into Subtopic 350-40. ASU 2025-06 is effective for public business entities beginning after December 15, 2027, with early adoption permitted. Entities may adopt the guidance on a prospective, modified retrospective, or full retrospective basis. The Company has not early adopted ASU 2025-06 and is evaluating the impact of the guidance but does not expect adoption to materially change the nature of costs eligible for capitalization or the point at which software is considered substantially complete and ready for its intended use. The Company has evaluated other recently issued accounting pronouncements and does not expect any such standards to have a material impact on its financial position, results of operations, or cash flows.

3. Bitcoin and Digital Assets Below is a rollforward of the bitcoin held for the three months ended March 31, 2026 and 2025. The USD column reflects the fair market value of the bitcoin held by the Company as of the period end (March 31st) dates, along with the fair value at the point in time of purchase, contribution, or sale for the respective transactions completed throughout the course of the periods presented. Schedule of Bitcoin Holdings <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bitcoin Holdings</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">BTC</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">USD</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold">December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_ecustom--BitcoinHoldingsNumberOfUnits_iS_uPure_c20250101__20250331_zCTmuUiuT7K7" style="width: 16%; text-align: right" title="Balance of bitcoin holdings in BTC">10.617</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CryptoAssetFairValue_iS_c20250101__20250331_z3P4Tm2qutph" style="width: 16%; text-align: right" title="Balance of bitcoin holdings in USD">992,437</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Purchases</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--BitcoinPurchase_uPure_c20250101__20250331_zoHhZoTyI9gj" style="text-align: right" title="Purchases of BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--CryptoAssetPurchase_c20250101__20250331_zIxUvQolVGWa" style="text-align: right" title="Purchases of bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale proceeds</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ProceedsFromSaleOfBitcoin_uPure_c20250101__20250331_zojQ9wPKTp3e" style="text-align: right" title="Sale proceeds from BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CryptoAssetSale_c20250101__20250331_z1WmC1wrhXN9" style="text-align: right" title="Sale proceeds from bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unrealized loss on bitcoin</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--UnrealizeLossOnBitcoin_uPure_c20250101__20250331_znTs2yOfAbD3" style="text-align: right" title="Unrealized loss on BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--CryptoAssetUnrealizedLossOperating_iN_di_c20250101__20250331_zFXoB5U43XCl" style="text-align: right" title="Unrealized loss on bitcoin in USD">(115,338</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Realized gain on bitcoin</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--RealizedGainOnBitcoin_uPure_c20250101__20250331_zdVLZOLQuTRh" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on BTC">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--CryptoAssetRealizedLossOperating_c20250101__20250331_zdrO7FcPqhw8" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on bitcoin in USD">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--BitcoinHoldingsNumberOfUnits_iE_uPure_c20250101__20250331_z2QyiftYBT22" style="text-align: right" title="Balance of bitcoin holdings in BTC">10.617</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--CryptoAssetFairValue_iE_c20250101__20250331_zJp27akfsFC5" style="text-align: right" title="Balance of bitcoin holdings in USD">877,099</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--BitcoinHoldingsNumberOfUnits_iS_uPure_c20260101__20260331_zanXhsOzPORk" style="text-align: right" title="Balance of bitcoin holdings in BTC">11.690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CryptoAssetFairValue_iS_c20260101__20260331_zxUSGCk6ZiD6" style="text-align: right" title="Balance of bitcoin holdings in USD">1,023,306</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Purchases</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--BitcoinPurchase_uPure_c20260101__20260331_zHRuoHvOyuS" style="text-align: right" title="Purchases of BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--CryptoAssetPurchase_c20260101__20260331_zI29eD0yKq82" style="text-align: right" title="Purchases of bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sale proceeds</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ProceedsFromSaleOfBitcoin_uPure_c20260101__20260331_zzGyjDP9Ebdc" style="text-align: right" title="Sale proceeds from BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--CryptoAssetSale_c20260101__20260331_zu2KNdHq3LT9" style="text-align: right" title="Sale proceeds from bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unrealized loss on bitcoin</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--UnrealizeLossOnBitcoin_uPure_c20260101__20260331_zxmpNftglswe" style="text-align: right" title="Unrealized loss on BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--CryptoAssetUnrealizedLossOperating_iN_di_c20260101__20260331_zHKLYwZs9d74" style="text-align: right" title="Unrealized loss on bitcoin in USD">(225,356</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Realized gain on bitcoin</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--RealizedGainOnBitcoin_uPure_c20260101__20260331_zAePGOyv1zFf" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on BTC">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--CryptoAssetRealizedLossOperating_c20260101__20260331_zMmvjgnTcU12" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on bitcoin in USD">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--BitcoinHoldingsNumberOfUnits_iE_uPure_c20260101__20260331_zIZ8R2Hdzpi9" style="text-align: right" title="Balance of bitcoin holdings in BTC">11.690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CryptoAssetFairValue_iE_c20260101__20260331_zknm20XdUT3f" style="text-align: right" title="Balance of bitcoin holdings in USD">797,950</td><td style="text-align: left"> </td></tr> </table> Below is a breakdown of the cost of the bitcoin acquired, as well as the unrealized gain that in total reflects the fair market value on the condensed balance sheets. Schedule of Fair Market Value <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20260331_zGsv2aSyxOy9" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20251231_z0P7iTzTwTUj" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--CryptoAssetCost_iI_zMVsuQkKCXSk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Cost Basis</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">570,659</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">570,659</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unrealized Gain</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--CryptoAssetUnrealizedGainOperating_c20260101__20260331_zMzL7kyrwUWc" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized Gain">227,291</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--CryptoAssetUnrealizedGainOperating_c20250101__20251231_z9Y5O12Fvvbj" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized Gain">452,647</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CryptoAssetFairValue_iI_zEKOxMpinAb5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total fair market value of bitcoin held</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">797,950</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,023,306</td><td style="text-align: left"> </td></tr> </table>

Schedule of Bitcoin Holdings <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bitcoin Holdings</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">BTC</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">USD</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold">December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_ecustom--BitcoinHoldingsNumberOfUnits_iS_uPure_c20250101__20250331_zCTmuUiuT7K7" style="width: 16%; text-align: right" title="Balance of bitcoin holdings in BTC">10.617</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CryptoAssetFairValue_iS_c20250101__20250331_z3P4Tm2qutph" style="width: 16%; text-align: right" title="Balance of bitcoin holdings in USD">992,437</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Purchases</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--BitcoinPurchase_uPure_c20250101__20250331_zoHhZoTyI9gj" style="text-align: right" title="Purchases of BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--CryptoAssetPurchase_c20250101__20250331_zIxUvQolVGWa" style="text-align: right" title="Purchases of bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale proceeds</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ProceedsFromSaleOfBitcoin_uPure_c20250101__20250331_zojQ9wPKTp3e" style="text-align: right" title="Sale proceeds from BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CryptoAssetSale_c20250101__20250331_z1WmC1wrhXN9" style="text-align: right" title="Sale proceeds from bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unrealized loss on bitcoin</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--UnrealizeLossOnBitcoin_uPure_c20250101__20250331_znTs2yOfAbD3" style="text-align: right" title="Unrealized loss on BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--CryptoAssetUnrealizedLossOperating_iN_di_c20250101__20250331_zFXoB5U43XCl" style="text-align: right" title="Unrealized loss on bitcoin in USD">(115,338</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Realized gain on bitcoin</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--RealizedGainOnBitcoin_uPure_c20250101__20250331_zdVLZOLQuTRh" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on BTC">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--CryptoAssetRealizedLossOperating_c20250101__20250331_zdrO7FcPqhw8" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on bitcoin in USD">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--BitcoinHoldingsNumberOfUnits_iE_uPure_c20250101__20250331_z2QyiftYBT22" style="text-align: right" title="Balance of bitcoin holdings in BTC">10.617</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--CryptoAssetFairValue_iE_c20250101__20250331_zJp27akfsFC5" style="text-align: right" title="Balance of bitcoin holdings in USD">877,099</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--BitcoinHoldingsNumberOfUnits_iS_uPure_c20260101__20260331_zanXhsOzPORk" style="text-align: right" title="Balance of bitcoin holdings in BTC">11.690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CryptoAssetFairValue_iS_c20260101__20260331_zxUSGCk6ZiD6" style="text-align: right" title="Balance of bitcoin holdings in USD">1,023,306</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Purchases</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--BitcoinPurchase_uPure_c20260101__20260331_zHRuoHvOyuS" style="text-align: right" title="Purchases of BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--CryptoAssetPurchase_c20260101__20260331_zI29eD0yKq82" style="text-align: right" title="Purchases of bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sale proceeds</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ProceedsFromSaleOfBitcoin_uPure_c20260101__20260331_zzGyjDP9Ebdc" style="text-align: right" title="Sale proceeds from BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--CryptoAssetSale_c20260101__20260331_zu2KNdHq3LT9" style="text-align: right" title="Sale proceeds from bitcoin in USD">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unrealized loss on bitcoin</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--UnrealizeLossOnBitcoin_uPure_c20260101__20260331_zxmpNftglswe" style="text-align: right" title="Unrealized loss on BTC">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--CryptoAssetUnrealizedLossOperating_iN_di_c20260101__20260331_zHKLYwZs9d74" style="text-align: right" title="Unrealized loss on bitcoin in USD">(225,356</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Realized gain on bitcoin</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--RealizedGainOnBitcoin_uPure_c20260101__20260331_zAePGOyv1zFf" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on BTC">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--CryptoAssetRealizedLossOperating_c20260101__20260331_zMmvjgnTcU12" style="border-bottom: Black 1pt solid; text-align: right" title="Realized gain on bitcoin in USD">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--BitcoinHoldingsNumberOfUnits_iE_uPure_c20260101__20260331_zIZ8R2Hdzpi9" style="text-align: right" title="Balance of bitcoin holdings in BTC">11.690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CryptoAssetFairValue_iE_c20260101__20260331_zknm20XdUT3f" style="text-align: right" title="Balance of bitcoin holdings in USD">797,950</td><td style="text-align: left"> </td></tr> </table>

10.617

992437

115338

10.617

877099

11.690

1023306

225356

11.690

797950

Below is a breakdown of the cost of the bitcoin acquired, as well as the unrealized gain that in total reflects the fair market value on the condensed balance sheets. Schedule of Fair Market Value <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20260331_zGsv2aSyxOy9" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20251231_z0P7iTzTwTUj" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--CryptoAssetCost_iI_zMVsuQkKCXSk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Cost Basis</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">570,659</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">570,659</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unrealized Gain</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--CryptoAssetUnrealizedGainOperating_c20260101__20260331_zMzL7kyrwUWc" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized Gain">227,291</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--CryptoAssetUnrealizedGainOperating_c20250101__20251231_z9Y5O12Fvvbj" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized Gain">452,647</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CryptoAssetFairValue_iI_zEKOxMpinAb5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total fair market value of bitcoin held</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">797,950</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,023,306</td><td style="text-align: left"> </td></tr> </table>

570659

227291

452647

797950

1023306

4. Fair Value of Financial Instruments The Company applies the fair value hierarchy established in ASC 820, Fair Value Measurement, which prioritizes the inputs used to measure fair value into three levels. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Level 1 inputs are quoted prices in active markets for identical assets or liabilities.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Level 2 inputs are observable inputs other than quoted prices included in Level 1.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Level 3 inputs are unobservable inputs.</td></tr></table> The Company’s financial instruments primarily consist of cash, bitcoin, accounts receivable, accounts payable, and credit card payable. The carrying amounts of cash, accounts receivable, accounts payable, and credit card payable approximate their fair values because of the short-term nature of these instruments. Recurring Measurement Bitcoin is measured at fair value on a recurring basis, as described above, using quoted prices in active markets (Level 1). As of March 31, 2026 and December 31, 2025, the Company did not have any financial instruments measured at fair value that were classified as Level 2 or Level 3. See Note 3 for more information regarding the Company’s bitcoin. The following tables present the Company’s financial assets measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025: Schedule of Financial Assets Measured at Fair Value Recurring Basis As of March 31, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">(in USD)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaNvpfO8Jo74" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLM6Blz6WHH4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zH02PU5KS623" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zH9Bw76frQAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--CryptoAssetFairValue_iI_zeTeQw1h1w1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Bitcoin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">797,950</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">797,950</td><td style="width: 1%; text-align: left"> </td></tr> </table> As of December 31, 2025 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">(in USD)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zwvZvprZmTO" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0M9z3t2FPj2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFFWqRrgWFra" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20251231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgfqsIlawUN9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--CryptoAssetFairValue_iI_zrhvRr5JWud8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Bitcoin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,023,306</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,023,306</td><td style="width: 1%; text-align: left"> </td></tr> </table>

The following tables present the Company’s financial assets measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025: Schedule of Financial Assets Measured at Fair Value Recurring Basis As of March 31, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">(in USD)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaNvpfO8Jo74" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLM6Blz6WHH4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zH02PU5KS623" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zH9Bw76frQAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--CryptoAssetFairValue_iI_zeTeQw1h1w1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Bitcoin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">797,950</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">797,950</td><td style="width: 1%; text-align: left"> </td></tr> </table> As of December 31, 2025 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">(in USD)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zwvZvprZmTO" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0M9z3t2FPj2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFFWqRrgWFra" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20251231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgfqsIlawUN9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--CryptoAssetFairValue_iI_zrhvRr5JWud8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Bitcoin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,023,306</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,023,306</td><td style="width: 1%; text-align: left"> </td></tr> </table>

797950

1023306

5. Capitalized Software Costs, Net The Company’s capitalized software costs, net consist of the following at March 31, 2026 and December 31, 2025: Schedule of Capitalized Software Costs, Net <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20260331_z3PAUWFDJgL5" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20251231_zqmaStAwdmG8" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Category</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Useful Life</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--CapitalizedComputerSoftwareGross_iI_z9REERC8IOz9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 29%; text-align: left">Software costs</td><td style="width: 2%"> </td> <td style="width: 29%"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_fMzMz_zLstn1W7Hxzb" title="Useful life">5 years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,680,515</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,456,063</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_di_z5gqV5xyqV7j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,277,306</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,093,750</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareNet_iI_zkVBCzrKZh3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Capitalized software costs, net</td><td> </td> <td> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,403,209</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,362,313</td><td style="text-align: left"> </td></tr> </table> Amortization expense was $183,556 and $121,197 for three months ended March 31, 2026 and 2025, respectively. Total capitalized software development costs were $224,452 and $185,077 for the three months ended March 31, 2026 and 2025, respectively. These amounts are inclusive of $43,065 and $66,785 of stock-based compensation capitalized for the three months ended March 31, 2026 and 2025, respectively.

The Company’s capitalized software costs, net consist of the following at March 31, 2026 and December 31, 2025: Schedule of Capitalized Software Costs, Net <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20260331_z3PAUWFDJgL5" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20251231_zqmaStAwdmG8" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Category</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Useful Life</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--CapitalizedComputerSoftwareGross_iI_z9REERC8IOz9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 29%; text-align: left">Software costs</td><td style="width: 2%"> </td> <td style="width: 29%"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_pid_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_fMzMz_zLstn1W7Hxzb" title="Useful life">5 years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,680,515</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,456,063</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_di_z5gqV5xyqV7j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,277,306</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,093,750</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareNet_iI_zkVBCzrKZh3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Capitalized software costs, net</td><td> </td> <td> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,403,209</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,362,313</td><td style="text-align: left"> </td></tr> </table>

P5Y

3680515

3456063

1277306

1093750

2403209

2362313

183556

121197

224452 185077 43065 66785

6. Computer Equipment, Net Computer equipment, net consisted of the following as of March 31, 2026 and December 31, 2025: Schedule of Capitalized Software Costs, Net <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_494_20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zba19gELP9a" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_496_20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_znGdJr4CG4Gi" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_zae84ddEVEL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Computer equipment, at cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,102</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,102</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_z1lMB0GRNV14" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,183</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iI_znEM1n6r8G27" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer equipment, net</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,919</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,511</td><td style="text-align: left"> </td></tr> </table> Depreciation expense for the three months ended March 31, 2026 and 2025, was $592 and $0, respectively. The computer equipment was placed in service during the year ended December 31, 2025 and represents the first year of depreciation.

Computer equipment, net consisted of the following as of March 31, 2026 and December 31, 2025: Schedule of Capitalized Software Costs, Net <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_494_20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zba19gELP9a" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_496_20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_znGdJr4CG4Gi" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_zae84ddEVEL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Computer equipment, at cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,102</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,102</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_z1lMB0GRNV14" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,183</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iI_znEM1n6r8G27" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computer equipment, net</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,919</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,511</td><td style="text-align: left"> </td></tr> </table>

7102

1183

591

5919

6511

592

7. Leases The Company leases office space under noncancelable operating leases. Short-term Office Leases Starting in November 2025, the Company utilizes office space via a 12-month operating lease which includes no long-term obligation. Rent related to short-term leases is recorded on a monthly basis as the expense is incurred and no liability is recognized on the balance sheets related to these leases as the Company has elected the short-term lease practical expedient. Long-term Office Lease In November 2024, the Company entered into a 13-month noncancellable operating lease for office space. Upon lease commencement, the Company recognized a ROU asset and a corresponding operating lease liability. The lease was not renewed upon completion of the 13-month term (ending November 30, 2025) and the ROU asset and associated lease liability were $0 as of December 31, 2025. Because the discount rate implicit in the lease was not readily determinable, the Company estimated its incremental borrowing rate using information about the Company’s credit profile, market yields on debt instruments with similar maturities, and the term of the lease. The Company applied this incremental borrowing rate of 7.5 percent in measuring the lease liability at the commencement date. Lease cost and cash flow information Lease cost for the three months ended March 31, 2026 and 2025 consisted of the following: Schedule of Lease Cost <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Lease cost component</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zjE94hbyKV34" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250331_zFzM8f8tGlKl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseCost_maLCzyTI_zHXSg7iNwn0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,811</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ShortTermLeaseCost_maLCzyTI_zD4Us0DMWtUj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Short term lease cost</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,582</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LeaseCost_iT_mtLCzyTI_zjBSlHrhEhQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total lease cost</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,582</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,811</td><td style="text-align: left"> </td></tr> </table> Lease cost is included within general and administrative expenses in the condensed statements of operations. Cash paid for amounts included in the measurement of operating lease liabilities was $0 and $1,811 for the three months ended March 31, 2026 and 2025, respectively.

0.075

Lease cost for the three months ended March 31, 2026 and 2025 consisted of the following: Schedule of Lease Cost <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Lease cost component</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zjE94hbyKV34" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250331_zFzM8f8tGlKl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseCost_maLCzyTI_zHXSg7iNwn0c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,811</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ShortTermLeaseCost_maLCzyTI_zD4Us0DMWtUj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Short term lease cost</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,582</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LeaseCost_iT_mtLCzyTI_zjBSlHrhEhQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total lease cost</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,582</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,811</td><td style="text-align: left"> </td></tr> </table>

1811

2582

1811

8. Stockholders’ Equity The Company’s common stock and preferred stock consist of the following at March 31, 2026 and December 31, 2025. There was a 2-for-1 stock split of common and preferred shares on August 31, 2025. In addition, in connection with the Company’s IPO which closed on May 18, 2026, the Company effected a <span id="xdx_90E_eus-gaap--StockholdersEquityNoteStockSplit_c20260514__20260514__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSTH5gW72pW6" title="Stock split">3.57-for-1 stock split of the Company’s common stock on May 14, 2026, the effective date of the registration statement used in connection with the IPO. The impact of these stock splits have been retroactively applied to all periods presented within the accompanying condensed financial statements, including all earnings per share calculations. Schedule of Stockholders’ Equity Common Stock <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zzptKbd5zGbc" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zxg0aOY1N85" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_eus-gaap--CommonStockSharesAuthorized_iI_pid_zNQGh9klmbqi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">13,969,410</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">13,969,410</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,084,208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,426,400</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_zg3eMCvDziPd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table> Preferred Stock <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zToUmPEYcdF7" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zr14HO1sQtMl" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Series Seed 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zR5kmvNcxfo" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">516,298</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">516,298</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zBYBQRwbz7uh" title="Preferred stock, shares outstanding">516,298</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zIjkPa5JQoH1" title="Preferred stock, shares outstanding">516,298</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zqijpIaKMO46" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zanHWyHcuj26" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zTtZtaIEYELf" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Series Seed 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_eus-gaap--PreferredStockSharesAuthorized_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zttsfLfIDwTl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">115,038</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">115,038</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zsJytGabemjf" title="Preferred stock, shares outstanding">115,038</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zTfM85bA4Vc5" title="Preferred stock, shares outstanding">115,038</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zG7D1qZWiM4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zG05JurjySVj" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_z3YrfIjauMpc" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Series A</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockSharesAuthorized_iI_pid_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z9QfTcbqU0Ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">687,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">687,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zCGN4LOKmeYe" title="Preferred stock, shares outstanding">611,299</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zTfFrEYtIMSl" title="Preferred stock, shares outstanding">611,299</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWT1ZCGrs8N3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table> Prepaid Equity Issuance Costs The Company has recorded $<span id="xdx_90A_ecustom--PrepaidEquityIssuanceCosts_iI_c20260331__us-gaap--StatementOfFinancialPositionLocationBalanceAxis__us-gaap--PrepaidExpenseCurrentAndNoncurrent_zUgjJDz38JY9" title="Prepaid equity issuance costs">607,903 and $<span id="xdx_90C_ecustom--PrepaidEquityIssuanceCosts_iI_c20251231__us-gaap--StatementOfFinancialPositionLocationBalanceAxis__us-gaap--PrepaidExpenseCurrentAndNoncurrent_z58aIRSoRL2c" title="Prepaid equity issuance costs">291,536 of costs incurred in connection with its IPO as a prepaid expense on the accompanying condensed balance sheets as of March 31, 2026 and December 31, 2025, respectively. Of these costs, $<span id="xdx_908_ecustom--PrepaidEquityIssuanceCosts_iI_c20260331__us-gaap--StatementOfFinancialPositionLocationBalanceAxis__us-gaap--AccountsPayableCurrentAndNoncurrent_zwPOQnBJpnm" title="Prepaid equity issuance costs">217,983 and $<span id="xdx_904_ecustom--PrepaidEquityIssuanceCosts_iI_c20251231__us-gaap--StatementOfFinancialPositionLocationBalanceAxis__us-gaap--AccountsPayableCurrentAndNoncurrent_zjz3LL160Kc4" title="Prepaid equity issuance costs">135,133 remains in accounts payable as of March 31, 2026 and December 31, 2025, respectively. These costs consist primarily of legal and professional fees that are directly attributable to the equity offering which was completed in May 2026. In accordance with ASC 340-10, incremental costs directly associated with a planned equity offering are deferred and recorded as an asset when it is probable that the offering will occur. Upon completion of the IPO, these deferred costs were reclassified from prepaid expenses and recorded as a reduction of the gross proceeds received, reflected within additional paid-in capital (APIC) in stockholders’ equity. No amortization or expense is recognized during the deferral period. Series A Preferred Stock Financing In August 2025, the Company completed a Series A preferred stock financing, issuing 611,299 shares of Series A preferred stock, with a par value of $0.001 per share, at a price of $6.54627 per share, resulting in total gross proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_c20250801__20250831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbyxvaxkDuSd" title="Proceeds from issuance of preferred stock">4,001,728. Also, in connection with the Series A financing, the Company issued common stock warrants to Series A investors and to certain existing preferred stockholders. These warrants are exercisable for an aggregate of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20250831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zO5RXkWR5J57" title="Warrants excercisable">893,393 shares of common stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z9hPtg2IEn8c" title="Warrants excercise price">0.003 per share. Because the Series A preferred shares were issued together with the Company’s Series A Warrants (as defined below) as part of a bundled financing arrangement, the Company allocated the total Series A proceeds between the preferred shares and the warrants using the relative fair value method. Based on this allocation approach, the Company assigned $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_c20250801__20250831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zURvYZ2NEbd9" title="Proceeds from issuance of preferred stock">3,396,563 of the Series A proceeds to the Series A preferred shares, with the remainder allocated to the equity-classified Series A Warrants. In connection with the Series A financing, the Company effected a <span id="xdx_90D_eus-gaap--StockholdersEquityNoteStockSplit_c20250801__20250831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zhNecREq89le" title="Stock split"><span id="xdx_901_eus-gaap--StockholdersEquityNoteStockSplit_c20250801__20250831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztOBFnSXrSU1" title="Stock split">2 for 1 forward stock split of its common stock and preferred stock on August 31, 2025. As a result of the stock split, each share of common and preferred stock outstanding at the time of the split was split into two shares, and the number of shares of common stock reserved for issuance under the Company’s equity incentive plan and upon the exercise or conversion of outstanding equity awards and other equity linked securities was proportionately increased. In addition to the Series A financing discussed above, in November 2025, the Company completed a rebalancing of its common stock, whereby one individual surrendered 1,148,055 shares of common stock to the Company, at which time the Company immediately cancelled and retired the shares. The Company also issued <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20251130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TwoStockholdersMember_zozdArvlXcp7" title="Common stock, shares issued">574,027 shares of common stock each to two stockholders (for total shares issued of 1,148,055) at a purchase price of $0.26 per share. Of each stockholder’s shares, <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20251101__20251130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaSSqxhwiXZg" title="Shares vested">466,396 are considered fully vested at the time of grant, while the remaining shares vest evenly on a monthly basis following the date of grant with all shares becoming fully vested on July 15, 2026. In connection with the transactions above, the Company also modified its Certificate of Incorporation during 2025 to increase its authorized common stock shares to 13,969,410 and its authorized preferred stock shares to 1,318,836, of which <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_z1ctDUXs9hr7" title="Preferred stock, shares authorized">516,298 shares are designated as Series Seed 1 shares, <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zc8dMPGWnNp1" title="Preferred stock, shares authorized">115,038 shares are designated as Series Seed 2 shares, and <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_za7tR3opsiDa" title="Preferred stock, shares authorized">687,500 shares are designated as Series A shares. Additionally, the Company modified its 2022 Equity Incentive Plan, first increasing the common stock shares reserved under the plan to <span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20251130__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_z8lrmaGpjhac" title="Common stock, shares reserved">2,447,046 but then subsequently decreasing it to <span id="xdx_905_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20251201__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_z1dKtQNwFRil" title="Common stock, shares reserved">1,298,991 shares. Holders of common stock are entitled to one vote per share and to receive dividends when and if declared by the Board of Directors, subject to the rights of any preferred stock then outstanding. No dividends had been declared or paid on common stock during the three month periods ended March 31, 2026 or 2025. The preferred stock were convertible into common stock at the option of the holder at any time after issuance at an initial conversion ratio of one-for-one, subject to adjustment for stock dividends, stock splits, combinations and other recapitalizations and for certain dilutive issuances, as set forth in the Company’s Amended and Restated Certificate of Incorporation. <span id="xdx_901_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zmHZDMwkxiFe" title="Preferred stock, terms of conversion">Each share of preferred stock was to automatically convert into common stock upon the closing of the sale of shares of the Company’s common stock to the public in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act at a per share price of at least five times the Series Seed-1 original issue price and resulting in at least $50,000,000 of gross proceeds to the Company, in connection with which the common stock is listed for trading on a national securities exchange approved by the Board of Directors, including the preferred director. Preferred stock was to also automatically convert into common stock upon the date and time, or the occurrence of an event, specified by vote or written consent of the “Requisite Holders,” defined as the holders of at least 63 percent of the outstanding shares of Series Seed-1 preferred stock. Holders of preferred stock were entitled to receive, out of any funds legally available therefor and only when, as and if declared by the Board of Directors, noncumulative dividends at the rate of 8 percent of the applicable original issue price per share, prior and in preference to any declaration or payment of any other dividends on shares of capital stock other than dividends on common stock payable solely in additional shares of common stock. In addition, if the Company declared or paid any dividends or other distributions on the common stock or on any class or series of stock that is convertible into common stock, the holders of preferred stock were entitled to receive an additional dividend or distribution on an as-converted basis, such that they would have received the same dividend or distribution they would have received if all shares of preferred stock had been converted into common stock. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, or a deemed liquidation event as defined in the Amended and Restated Certificate of Incorporation, the holders of preferred stock were entitled to receive, prior and in preference to any distribution to the holders of common stock, an amount per share equal to the greater of (i) one times the applicable original issue price per share plus any declared but unpaid dividends, or (ii) the amount that would have been payable with respect to such share if all shares of preferred stock were converted into common stock immediately prior to such event. If, upon such liquidation, dissolution, winding up or deemed liquidation event, the assets or proceeds available for distribution were insufficient to permit the full payment of such amounts, the available assets and proceeds would have been distributed among the holders of preferred stock on a pro rata basis in proportion to the full preferential amounts to which they were entitled. After payment in full of the amounts that would have been required to be distributed to the holders of preferred stock, the remaining assets of the Company, if any, would have been distributed among the holders of common stock on a pro rata basis. The preferred stock ranked senior to the common stock with respect to dividend rights and rights on liquidation. The liquidation value of Series Seed 1 preferred stock was $<span id="xdx_90B_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zY1tXcJqS16k" title="Preferred stock, liquidation preference value"><span id="xdx_90E_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zDxPCBmliKo2" title="Preferred stock, liquidation preference value">3,231,354 as of March 31, 2026 and December 31, 2025. The liquidation value of the Series Seed 2 was $<span id="xdx_900_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zUbpnWKs8U6g" title="Preferred stock, liquidation preference value"><span id="xdx_90B_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zbQ18KfUYbuk" title="Preferred stock, liquidation preference value">599,992 as of March 31, 2026 and December 31, 2025. The liquidation value of the Series A preferred stock was $<span id="xdx_907_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zzN7OM3imLQe" title="Preferred stock, liquidation preference value"><span id="xdx_904_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zKeOMFugniL5" title="Preferred stock, liquidation preference value">4,001,728 as of March 31, 2026 and December 31, 2025. Combined liquidation value of all preferred stock as of March 31, 2026 and December 31, 2025 was $7,833,074. All classes of preferred stock voted together with the common stock on an as-converted basis and, so long as any preferred stock remained outstanding, had certain protective rights that required the written consent or affirmative vote of the Requisite Holders, voting as a separate class, for specified significant corporate actions. These actions included, among other things, (i) any liquidation, dissolution or winding up of the Company or any merger, consolidation or other deemed liquidation event, (ii) amending the Amended and Restated Certificate of Incorporation or bylaws in a manner that adversely affected the powers, preferences or rights of the preferred stock, (iii) creating, authorizing or issuing any new class or series of capital stock that was senior to or on parity with the preferred stock, or changing the authorized number of shares of common stock or preferred stock, (iv) declaring or paying dividends or making other distributions on, or purchasing or redeeming, shares of capital stock other than as expressly permitted, (v) adopting or materially amending equity compensation plans or issuing equity or equity-linked awards outside such plans without Board approval including the preferred director, (vi) incurring indebtedness for borrowed money above specified thresholds or granting certain liens, (vii) entering into certain related party transactions, and (viii) changing the authorized size of the Board of Directors or altering the director election structure. Additional Paid-in Capital Additional paid-in capital primarily reflects amounts received from founders and investors in excess of the par value of the Company’s common and preferred stock. Warrants Description of Warrants In connection with the Company’s Series A financing completed in August 2025, the Company issued warrants to select stockholders to purchase an aggregate of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20250831__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zP7RIALoNmlh" title="Purchase of warrants">893,393 shares of common stock (the “Series A Warrants”). The Series A Warrants have an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250831__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zSR3XhZ7E14g" title="Warrants, exercise price">0.003 per share, are exercisable upon vesting (as described below), and expire ten years from the issuance date, unless earlier terminated pursuant to a change in control as defined in the warrant agreements. The Series A Warrants vest upon the earlier of: 1) the Company achieving a public market capitalization of at least $100 million, or 2) a determination by the Company’s Board of Directors that the Company’s enterprise value is at least $100 million. All Series A Warrants were issued in connection with the Series A closing on August 31, 2025, which represents the common grant and measurement date for valuation purposes. The Company evaluated the Series A Warrants under ASC 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity. Management concluded that the Series A Warrants are: 1) indexed to the Company’s own stock, and 2) meet all conditions for equity classification, including that settlement is in a fixed number of shares and does not require cash settlement. Accordingly, the Series A Warrants are classified as equity and recorded within additional paid-in capital on the statement of stockholders’ equity. As equity-classified instruments, the Series A Warrants are not subsequently remeasured. Because the Series A Warrants are equity-classified and were issued together with the Company’s Series A preferred stock in a bundled financing, the Company allocated a portion of the Series A proceeds to the Series A Warrants using the relative fair value method, with the offset recorded as a reduction to proceeds attributed to the Series A preferred stock. The fair value of the Series A Warrants was determined utilizing a backsolve option pricing model based on the Series A transaction price along with a Monte Carlo simulation which accounted for the Series A Warrants as market-conditioned awards based on the $100 million market capitalization or enterprise value vesting condition. The grant-date fair value of the Series A Warrants was determined as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif">●</td><td style="font: 10pt Times New Roman, Times, Serif">Fair value per warrant share: $0.80</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Total fair value of warrants issued: $712,977</td></tr></table> As a result, a fair value of $605,165 was assigned to the Series A Warrants under the relative fair value method for purposes of allocating the total $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_c20250801__20250831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWOweykqTLT6" title="Proceeds from issuance of preferred stock">4,001,728 Series A financing proceeds. Warrant Activity The following table summarizes warrant activity for the three months ended March 31, 2026: Summary of Warrant Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted- Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding at December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260331_z1cBujgZvXm9" style="width: 16%; text-align: right" title="Number of Shares, Oustanding">893,393</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331_zYAYpORJgAj9" style="width: 16%; text-align: right" title="Weighted-Average Exercise Price, Oustanding">0.003</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260101__20260331_zE72RZDWGtn9" style="text-align: right" title="Number of Shares, Issued">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zsQFypl6zYWf" style="text-align: right" title="Weighted-Average Exercise Price, Issued">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20260101__20260331_ztpO21YKULng" style="text-align: right" title="Number of Shares, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_z32T99mrKHm5" style="text-align: right" title="Weighted-Average Exercise Price, Excercised">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20260101__20260331_zMRJj8W0Ft9c" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zTrJcLNzOtyg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260331_ziRH3EFEaNAc" style="text-align: right" title="Number of Shares, Oustanding">893,393</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331_zkjUlOq2WLij" style="text-align: right" title="Weighted-Average Exercise Price, Oustanding">0.003</td><td style="text-align: left"> </td></tr> </table> With the warrants being issued in connection with the Series A Financing in August 2025, there was no warrant activity for the three-month period ended March 31, 2025. All warrants outstanding at March 31, 2026 and December 31, 2025 were unexercised and unvested. Significant Estimates and Judgments <p id="xdx_891_ecustom--ScheduleOfValuationPerformedUsingValuationAssumptionsAsOfGrantDateTableTextBlock_zGMHogW4KEkb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0">The valuation of the Series A Warrants required the use of significant assumptions, including expected volatility, risk-free interest rate, and the probability of achieving the market-based vesting condition. Schedule Of Valuation Performed Using Assumptions Key assumptions used in the valuation included: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Option pricing model expected term: <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260331__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputOptionPricingModelExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zOlaclYBvjLh" title="Warrants measurement input, term">1.5 years</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Warrant expected term: <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zeAiRpKBgU35" title="Warrants measurement input, term">10.0 years</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Volatility: <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zZpJpTGemPkh" title="Warrants measurement input">70%</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate: <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zczeFB8XNBL6" title="Warrants measurement input">4.23%</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Dividend yield: <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zWAKUKiACMya" title="Warrants measurement input">0%</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Simulation inputs: <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPathsMonthlyTimeStepsMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zNTgZo4H4pof" title="Warrants measurement input">100,000 paths with monthly time steps</td></tr></table>

2-for-1

3.57-for-1

Schedule of Stockholders’ Equity Common Stock <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zzptKbd5zGbc" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zxg0aOY1N85" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_eus-gaap--CommonStockSharesAuthorized_iI_pid_zNQGh9klmbqi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">13,969,410</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">13,969,410</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,084,208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,426,400</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_zg3eMCvDziPd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table> Preferred Stock <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zToUmPEYcdF7" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zr14HO1sQtMl" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Series Seed 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zR5kmvNcxfo" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">516,298</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">516,298</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zBYBQRwbz7uh" title="Preferred stock, shares outstanding">516,298</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zIjkPa5JQoH1" title="Preferred stock, shares outstanding">516,298</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_zqijpIaKMO46" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zanHWyHcuj26" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zTtZtaIEYELf" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Series Seed 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_eus-gaap--PreferredStockSharesAuthorized_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zttsfLfIDwTl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">115,038</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">115,038</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zsJytGabemjf" title="Preferred stock, shares outstanding">115,038</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zTfM85bA4Vc5" title="Preferred stock, shares outstanding">115,038</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_hus-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zG7D1qZWiM4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260331_zG05JurjySVj" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_z3YrfIjauMpc" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Series A</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockSharesAuthorized_iI_pid_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z9QfTcbqU0Ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Authorized shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">687,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">687,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zCGN4LOKmeYe" title="Preferred stock, shares outstanding">611,299</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zTfFrEYtIMSl" title="Preferred stock, shares outstanding">611,299</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWT1ZCGrs8N3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Par value per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> </table>

13969410

6084208

5426400

0.001

516298

0.001

115038

0.001

687500

611299

0.001

607903 291536 217983 135133

611299

0.001

6.54627

4001728

893393

0.003

3396563

2 for 1 forward stock split

1148055

574027

1148055

0.26

466396

13969410

1318836

516298

115038

687500

2447046

1298991

Each share of preferred stock was to automatically convert into common stock upon the closing of the sale of shares of the Company’s common stock to the public in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act at a per share price of at least five times the Series Seed-1 original issue price and resulting in at least $50,000,000 of gross proceeds to the Company, in connection with which the common stock is listed for trading on a national securities exchange approved by the Board of Directors, including the preferred director. Preferred stock was to also automatically convert into common stock upon the date and time, or the occurrence of an event, specified by vote or written consent of the “Requisite Holders,” defined as the holders of at least 63 percent of the outstanding shares of Series Seed-1 preferred stock.

3231354

599992

4001728

7833074

893393

0.003

P10Y

The Series A Warrants vest upon the earlier of: 1) the Company achieving a public market capitalization of at least $100 million, or 2) a determination by the Company’s Board of Directors that the Company’s enterprise value is at least $100 million. The fair value of the Series A Warrants was determined utilizing a backsolve option pricing model based on the Series A transaction price along with a Monte Carlo simulation which accounted for the Series A Warrants as market-conditioned awards based on the $100 million market capitalization or enterprise value vesting condition.

0.80

712977

605165

4001728

The following table summarizes warrant activity for the three months ended March 31, 2026: Summary of Warrant Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted- Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding at December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260331_z1cBujgZvXm9" style="width: 16%; text-align: right" title="Number of Shares, Oustanding">893,393</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331_zYAYpORJgAj9" style="width: 16%; text-align: right" title="Weighted-Average Exercise Price, Oustanding">0.003</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260101__20260331_zE72RZDWGtn9" style="text-align: right" title="Number of Shares, Issued">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zsQFypl6zYWf" style="text-align: right" title="Weighted-Average Exercise Price, Issued">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20260101__20260331_ztpO21YKULng" style="text-align: right" title="Number of Shares, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_z32T99mrKHm5" style="text-align: right" title="Weighted-Average Exercise Price, Excercised">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20260101__20260331_zMRJj8W0Ft9c" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zTrJcLNzOtyg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Expired">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260331_ziRH3EFEaNAc" style="text-align: right" title="Number of Shares, Oustanding">893,393</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331_zkjUlOq2WLij" style="text-align: right" title="Weighted-Average Exercise Price, Oustanding">0.003</td><td style="text-align: left"> </td></tr> </table>

893393

0.003

893393

0.003 <p id="xdx_891_ecustom--ScheduleOfValuationPerformedUsingValuationAssumptionsAsOfGrantDateTableTextBlock_zGMHogW4KEkb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0">The valuation of the Series A Warrants required the use of significant assumptions, including expected volatility, risk-free interest rate, and the probability of achieving the market-based vesting condition. Schedule Of Valuation Performed Using Assumptions Key assumptions used in the valuation included: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Option pricing model expected term: <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260331__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputOptionPricingModelExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zOlaclYBvjLh" title="Warrants measurement input, term">1.5 years</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Warrant expected term: <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zeAiRpKBgU35" title="Warrants measurement input, term">10.0 years</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Volatility: <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zZpJpTGemPkh" title="Warrants measurement input">70%</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate: <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zczeFB8XNBL6" title="Warrants measurement input">4.23%</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Dividend yield: <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zWAKUKiACMya" title="Warrants measurement input">0%</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Simulation inputs: <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPathsMonthlyTimeStepsMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zNTgZo4H4pof" title="Warrants measurement input">100,000 paths with monthly time steps</td></tr></table>

P1Y6M

P10Y

4.23

100000

9. Stock-Based Compensation During the three months ended March 31, 2026, the Company maintained the VIDA Global Inc. 2022 Equity Incentive Plan (the “Plan”) under which it was able to grant stock options, restricted stock awards, restricted stock units and other equity-based awards to employees, directors, and consultants. As of March 31, 2026, a total of <span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zE3Hx9AkUP3c" title="Common stock, shares reserved">1,731,211 shares of common stock were reserved for issuance under the Plan, of which <span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260401__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpN8lx1H5mah" title="Common stock, shares reserved">361,652 shares remained available for future grant as of that date. In April 2026, the Company’s board of directors and stockholders adopted the 2026 Omnibus Equity Incentive Plan (the “2026 Plan”). The 2026 Plan came into existence and became effective upon the effectiveness of the registration statement in connection with the IPO, after which no further grants will be made under the Plan. See Note 14 Subsequent Events for additional information. Stock Options Stock options are granted with an exercise price equal to at least the estimated fair value of the Company’s common stock on the date of grant, as determined by the Board of Directors with reference to contemporaneous third-party valuations and other factors. <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zOkNGatVdL3i" title="Vesting periods description">Options generally vest over four years with a one-year cliff and have a contractual term of ten years. <p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaMjxhnOZw63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The fair value of stock options is estimated on the grant date using the Black Scholes option pricing model with the following weighted average assumptions: Schedule of Assumption of Black-scholes Option Pricing Model For the three months ended March 31, 2026 and 2025: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Three months ended</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected Term (in years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">N/A</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">5.85</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69.16</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.14</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20250101__20250331_zkHze0xjfDYa" style="text-align: right" title="Expected dividend yield">0.00</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Grant date fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue_pid_c20250101__20250331_zTfcXhZlohE2" style="text-align: right" title="Grant date fair value">0.85</td><td style="text-align: left"> </td></tr> </table> A summary of stock option activity under the Plan for the three months ended March 31, 2026 and 2025 is as follows: Schedule of Stock Option Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Options</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contractual Life (years)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Outstanding at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250101__20250331_zPYSUlLAvmY7" style="width: 14%; text-align: right" title="Options Outstanding, Balance">8,568</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20250101__20250331_zqyowuy6f8Wa" style="width: 14%; text-align: right" title="Weighted Average Exercise Price, Balance">0.22</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zSiRJmxvtU6" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.22</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20250101__20250331_zDlCSTw0lbHa" style="text-align: right" title="Options Outstanding, Granted">145,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20250101__20250331_zFLIx3e3FJs3" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20250101__20250331_zqfB4gpr5jjh" style="text-align: right" title="Options Outstanding, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20250101__20250331_zLZEESYZsUB5" style="text-align: right" title="Weighted Average Exercise Price, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20250101__20250331_zsuLv9sM6bf1" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20250101__20250331_zQVXxAlJfny1" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20250101__20250331_zzRs1oUGAhgl" style="text-align: right" title="Options Outstanding, Balance">153,760</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20250101__20250331_zMYR6UM1B2r3" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20250331_z7bDLjR9MmDi" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20260101__20260331_zK2upbAL9sLe" style="text-align: right" title="Options Outstanding, Balance">711,751</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331_zZAOPrfJQMhh" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231_zUuDP4QcDqPh" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20260101__20260331_zipmgVdToA02" style="text-align: right" title="Options Outstanding, Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zwLTrY7CbnE9" style="text-align: right" title="Weighted Average Exercise Price, Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20260101__20260331_zS0hcK6AJzY1" style="text-align: right" title="Options Outstanding, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zJX0PXmP4u3l" style="text-align: right" title="Weighted Average Exercise Price, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20260101__20260331_zmK7olwcUO9" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zf1zLxA94Bfk" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20260101__20260331_zXfNII2DiGN" style="text-align: right" title="Options Outstanding, Balance">711,751</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331_zYl1V31whFSa" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331_zl53W17l8L4g" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.42</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercisable at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20260101__20260331_zvHUyAKJQoz5" style="text-align: right" title="Options Exercisable, Balance">58,017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260331_zZpZcWgbKk2" style="text-align: right" title="Weighted Average Exercise Price Exercisable, Balance">0.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331_zMxPh5RpSny8" title="Weighted Average Remaining Contractual Life (years) Exercisable, Outstanding Years">8.88</td><td style="text-align: left"> </td></tr> </table> During the three months ended March 31, 2026 and 2025, stock-based compensation from stock options totaled $24,787 and $1,715, respectively. For the three months ended March 31, 2026, $12,535 was expensed as a component of sales and marketing expense and $5,337 was expensed as a component of general and administrative expense on the condensed statement of operations while the remaining $6,915 was capitalized as a component of capitalized software costs. For the three months ended March 31, 2025, $1,513 was expensed as a component of sales and marketing expense and $202 was expensed as a component of general and administrative expense on the condensed statement of operations. No amounts were capitalized as a part of capitalized software costs for the three months ended March 31, 2025. At March 31, 2026 and December 31, 2025, the aggregate intrinsic value of stock options outstanding was approximately $330,000 and $267,000, respectively. At March 31, 2026 and December 31, 2025, the aggregate intrinsic value of stock options exercisable was approximately $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20260101__20260331_zzg50OiXbOA6" title="Stock options outstanding exercisable, intrinsic value">33,000 and $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20250101__20251231_zpWYz3JV7Z72" title="Stock options outstanding exercisable, intrinsic value">23,000, respectively. As of March 31, 2026, total unrecognized compensation cost related to stock options was $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYsCtUdzXU18" title="Unrecognized compensation cost">302,919, which is expected to be recognized over a weighted average period of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z560bLX1ikF8" title="Weighted-average remaining contractual life">3.34 years. Restricted Stock Awards <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkI7QkeiNCx5" title="Vesting periods description">The Company has also granted restricted common stock awards with varying vesting periods between 10 and 48 months based on continued service. The grant date fair value of these awards is based on the estimated fair value of the Company’s common stock on the grant date. Some of these common stock awards were restricted upon issuance while others were originally issued unrestricted but became restricted subsequent to issuance. A summary of unvested restricted stock awards for the periods ended March 31, 2026 and 2025 is as follows: Schedule of Unvested Restricted Stock Awards <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value Aggregate</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Unvested at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20250101__20250331_zv76kL4UZTOc" style="width: 14%; text-align: right" title="Shares unvested, outstanding balance">2,326,451</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20250101__20250331_z627ITIPPk4a" style="width: 14%; text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20250101__20250331_zoWht5XYGYRh" style="width: 14%; text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">1,038,288</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20250101__20250331_zM1deYtZIS6e" style="text-align: right" title="Shares unvested, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20250101__20250331_zfOMLIr2jDKc" style="text-align: right" title="Shares unvested weighted average grant date fair value, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20250101__20250331_zAt3SlEuenV1" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20250101__20250331_zbIxOkC2D9Re" style="text-align: right" title="Shares unvested, vested">(272,213</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20250101__20250331_zarKSgNQHDp8" style="text-align: right" title="Shares unvested weighted average grant date fair value, vested">0.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_iN_di_c20250101__20250331_zKAqCj2UXKD4" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, vested">(115,421</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20250101__20250331_zh79pVV5Owph" style="border-bottom: Black 1pt solid; text-align: right" title="Shares unvested, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20250101__20250331_zzESl65juWJ6" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20250101__20250331_zfSlKOhKbRjb" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value aggregate, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested at March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20250101__20250331_zwl2oOUCuzCh" style="text-align: right" title="Shares unvested, outstanding balance">2,054,238</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20250101__20250331_zYYQiXXRYqr5" style="text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.45</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20250101__20250331_znlyOtt9QPy4" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">922,867</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested at December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20260101__20260331_z1ROQRnXtcf4" style="text-align: right" title="Shares unvested, outstanding balance">1,118,013</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260331_zjLIEmRAkzq9" style="text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.48</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20260101__20260331_zazgPb5fTPZf" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">531,548</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20260101__20260331_zag5y2wbmlv1" style="text-align: right" title="Shares unvested, granted">657,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331_zLRvpmSlbWe9" style="text-align: right" title="Shares unvested weighted average grant date fair value, granted">0.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20260101__20260331_zaROgNNTLkx7" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, granted">456,044</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20260101__20260331_zuYnKssxOM4i" style="text-align: right" title="Shares unvested, vested">(290,155</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331_zgfLyvMbIgJa" style="text-align: right" title="Shares unvested weighted average grant date fair value, vested">0.45</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_iN_di_c20260101__20260331_zIVyx7YXOxoj" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, vested">(131,405</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20260101__20260331_zwDARy8wjGTa" style="border-bottom: Black 1pt solid; text-align: right" title="Shares unvested, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260331_znZxmKG8ybHk" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20260101__20260331_zSYklIfnU8Xj" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value aggregate, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20260101__20260331_znt0qzLtiF3e" style="text-align: right" title="Shares unvested, outstanding balance">1,485,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260331_zwmlULwRQkZh" style="text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20260101__20260331_zWSJoZZ89Zk3" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">857,108</td><td style="text-align: left"> </td></tr> </table> As of March 31, 2026, total unrecognized compensation cost related to unvested restricted stock was $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zAnaaM5Lcxgb" title="Unrecognized compensation cost">788,613, which is expected to be recognized over a weighted average period of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zisWdQpDWbTh" title="Weighted-average remaining contractual life">2.52 years. During the three months ended March 31, 2026, stock-based compensation from restricted stock totaled $145,637 of which $36,150 was capitalized as a component of capitalized software costs and the remaining $109,487 was expensed as a component of general and administrative expense on the condensed statement of operations. During the three months ended March 31, 2025, stock-based compensation from restricted stock totaled $119,666, of which $66,785 was capitalized as a component of capitalized software costs and the remaining $52,881 was expensed as a component of general and administrative expense on the condensed statement of operations.

1731211

361652

Options generally vest over four years with a one-year cliff and have a contractual term of ten years.

<p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaMjxhnOZw63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The fair value of stock options is estimated on the grant date using the Black Scholes option pricing model with the following weighted average assumptions: Schedule of Assumption of Black-scholes Option Pricing Model For the three months ended March 31, 2026 and 2025: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Three months ended</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected Term (in years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">N/A</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">5.85</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69.16</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.14</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20250101__20250331_zkHze0xjfDYa" style="text-align: right" title="Expected dividend yield">0.00</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Grant date fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue_pid_c20250101__20250331_zTfcXhZlohE2" style="text-align: right" title="Grant date fair value">0.85</td><td style="text-align: left"> </td></tr> </table>

P5Y10M6D

0.6916

0.0414

0.0000

0.85

A summary of stock option activity under the Plan for the three months ended March 31, 2026 and 2025 is as follows: Schedule of Stock Option Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Options</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contractual Life (years)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Outstanding at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250101__20250331_zPYSUlLAvmY7" style="width: 14%; text-align: right" title="Options Outstanding, Balance">8,568</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20250101__20250331_zqyowuy6f8Wa" style="width: 14%; text-align: right" title="Weighted Average Exercise Price, Balance">0.22</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231_zSiRJmxvtU6" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.22</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20250101__20250331_zDlCSTw0lbHa" style="text-align: right" title="Options Outstanding, Granted">145,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20250101__20250331_zFLIx3e3FJs3" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20250101__20250331_zqfB4gpr5jjh" style="text-align: right" title="Options Outstanding, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20250101__20250331_zLZEESYZsUB5" style="text-align: right" title="Weighted Average Exercise Price, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20250101__20250331_zsuLv9sM6bf1" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20250101__20250331_zQVXxAlJfny1" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20250101__20250331_zzRs1oUGAhgl" style="text-align: right" title="Options Outstanding, Balance">153,760</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20250101__20250331_zMYR6UM1B2r3" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20250331_z7bDLjR9MmDi" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20260101__20260331_zK2upbAL9sLe" style="text-align: right" title="Options Outstanding, Balance">711,751</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331_zZAOPrfJQMhh" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231_zUuDP4QcDqPh" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20260101__20260331_zipmgVdToA02" style="text-align: right" title="Options Outstanding, Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zwLTrY7CbnE9" style="text-align: right" title="Weighted Average Exercise Price, Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20260101__20260331_zS0hcK6AJzY1" style="text-align: right" title="Options Outstanding, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zJX0PXmP4u3l" style="text-align: right" title="Weighted Average Exercise Price, Exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20260101__20260331_zmK7olwcUO9" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331_zf1zLxA94Bfk" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20260101__20260331_zXfNII2DiGN" style="text-align: right" title="Options Outstanding, Balance">711,751</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331_zYl1V31whFSa" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331_zl53W17l8L4g" title="Weighted Average Remaining Contractual Life (years), Outstanding Years">9.42</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercisable at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20260101__20260331_zvHUyAKJQoz5" style="text-align: right" title="Options Exercisable, Balance">58,017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260331_zZpZcWgbKk2" style="text-align: right" title="Weighted Average Exercise Price Exercisable, Balance">0.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331_zMxPh5RpSny8" title="Weighted Average Remaining Contractual Life (years) Exercisable, Outstanding Years">8.88</td><td style="text-align: left"> </td></tr> </table>

8568

0.22

P9Y2M19D

145192

0.12

153760

0.13

P9Y10M17D

711751

0.23

P9Y7M28D

711751

0.23

P9Y5M1D

58017

0.13

P8Y10M17D

24787

1715

12535

5337

6915

1513

202

330000

267000

33000

23000

302919

P3Y4M2D

The Company has also granted restricted common stock awards with varying vesting periods between 10 and 48 months based on continued service.

A summary of unvested restricted stock awards for the periods ended March 31, 2026 and 2025 is as follows: Schedule of Unvested Restricted Stock Awards <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value Aggregate</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Unvested at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20250101__20250331_zv76kL4UZTOc" style="width: 14%; text-align: right" title="Shares unvested, outstanding balance">2,326,451</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20250101__20250331_z627ITIPPk4a" style="width: 14%; text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20250101__20250331_zoWht5XYGYRh" style="width: 14%; text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">1,038,288</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20250101__20250331_zM1deYtZIS6e" style="text-align: right" title="Shares unvested, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20250101__20250331_zfOMLIr2jDKc" style="text-align: right" title="Shares unvested weighted average grant date fair value, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20250101__20250331_zAt3SlEuenV1" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20250101__20250331_zbIxOkC2D9Re" style="text-align: right" title="Shares unvested, vested">(272,213</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20250101__20250331_zarKSgNQHDp8" style="text-align: right" title="Shares unvested weighted average grant date fair value, vested">0.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_iN_di_c20250101__20250331_zKAqCj2UXKD4" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, vested">(115,421</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20250101__20250331_zh79pVV5Owph" style="border-bottom: Black 1pt solid; text-align: right" title="Shares unvested, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20250101__20250331_zzESl65juWJ6" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20250101__20250331_zfSlKOhKbRjb" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value aggregate, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested at March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20250101__20250331_zwl2oOUCuzCh" style="text-align: right" title="Shares unvested, outstanding balance">2,054,238</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20250101__20250331_zYYQiXXRYqr5" style="text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.45</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20250101__20250331_znlyOtt9QPy4" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">922,867</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested at December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20260101__20260331_z1ROQRnXtcf4" style="text-align: right" title="Shares unvested, outstanding balance">1,118,013</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260331_zjLIEmRAkzq9" style="text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.48</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20260101__20260331_zazgPb5fTPZf" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">531,548</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20260101__20260331_zag5y2wbmlv1" style="text-align: right" title="Shares unvested, granted">657,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331_zLRvpmSlbWe9" style="text-align: right" title="Shares unvested weighted average grant date fair value, granted">0.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20260101__20260331_zaROgNNTLkx7" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, granted">456,044</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20260101__20260331_zuYnKssxOM4i" style="text-align: right" title="Shares unvested, vested">(290,155</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331_zgfLyvMbIgJa" style="text-align: right" title="Shares unvested weighted average grant date fair value, vested">0.45</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_iN_di_c20260101__20260331_zIVyx7YXOxoj" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, vested">(131,405</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Forfeited / cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20260101__20260331_zwDARy8wjGTa" style="border-bottom: Black 1pt solid; text-align: right" title="Shares unvested, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260331_znZxmKG8ybHk" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20260101__20260331_zSYklIfnU8Xj" style="padding-bottom: 1pt; text-align: right" title="Shares unvested weighted average grant date fair value aggregate, forfeited / cancelled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested at March 31, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20260101__20260331_znt0qzLtiF3e" style="text-align: right" title="Shares unvested, outstanding balance">1,485,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260331_zwmlULwRQkZh" style="text-align: right" title="Shares unvested weighted average grant date fair value, outstanding balance">0.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20260101__20260331_zWSJoZZ89Zk3" style="text-align: right" title="Shares unvested weighted average grant date fair value aggregate, outstanding balance">857,108</td><td style="text-align: left"> </td></tr> </table>

2326451

0.45

1038288

272213

0.42

115421

2054238

0.45

922867

1118013

0.48

531548

657808

0.69

456044

290155

0.45

131405

1485666

0.58

857108

788613

P2Y6M7D

145637

36150

109487

119666

66785

52881

10 Earnings (Loss) Per Share Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding, excluding shares of unvested restricted common stock. Shares of restricted stock as well as the Series A Warrants are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. The Series A Warrants are included in the calculation of diluted earnings per share to the extent that the warrants are dilutive and vesting conditions have been satisfied. Potential common shares are excluded from the computation when their effect is antidilutive. Basic and diluted net loss per common share is the same for the three months ended March 31, 2026 and 2025 because all stock options, unvested restricted common stock, and warrants are anti-dilutive. Schedule of Earnings (Loss) Per Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">EPS Computation</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260101__20260331_z8KYFxVuqDC6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20250101__20250331_zg7PqfyOkDY6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_zj0qF4UWR4o" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss available to common shareholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,112,244</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(522,033</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zv3uBETez0aj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Weighted-average common shares - basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,429,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,203,331</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_z3mJ745XwBfc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Effect of dilutive stock option</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_z5ldRXo2nAEe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Effect of dilutive unvested restricted stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zzXy8ptgA17a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Weighted-average common shares – diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,429,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,203,331</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasic_pid_zc82gcijBag2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Loss per share, basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.25</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.16</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareDiluted_pid_zMNbBi50W52k" style="vertical-align: bottom; background-color: White"> <td>Loss per share, diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.25</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td></tr> </table> The following are excluded from the calculation of diluted loss per share as their effect is antidilutive: As of March 31, 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Convertible preferred stock (as converted to common stock):</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">◌</td><td style="font: 10pt Times New Roman, Times, Serif">Series Seed 2 Preferred stock: <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zcomc9Hn8xm" title="Convertible preferred stock">115,038 shares</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">◌</td><td style="font: 10pt Times New Roman, Times, Serif">Series Seed 1 Preferred stock: <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_z9ti7Itb9LFg" title="Convertible preferred stock">516,298 shares</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">◌</td><td style="font: 10pt Times New Roman, Times, Serif">Series A Preferred stock: <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zb9JHxpNO3le" title="Convertible preferred stock">611,299 shares</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Stock options: 711,751 options outstanding</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Unvested restricted stock awards: 1,485,666 shares</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Series A Warrants: <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260331__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zPU9jYccX6di" title="Warrants shares, unvested">893,393 shares, unvested</td></tr></table> As of March 31, 2025: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Convertible preferred stock (as converted to common stock):</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">◌</td><td style="font: 10pt Times New Roman, Times, Serif">Series Seed 2 Preferred stock:<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedTwoPreferredStockMember_zqBPnWRNvd87" title="Convertible preferred stock">115,038 shares</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">◌</td><td style="font: 10pt Times New Roman, Times, Serif">Series Seed 1 Preferred stock: <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesSeedOnePreferredStockMember_z1Xhtiv2KOA8" title="Convertible preferred stock">516,298 shares</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Stock options: 153,760 options outstanding</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif">Unvested restricted stock awards: 2,054,238 shares</td></tr></table> All share and per share amounts have been retroactively adjusted to reflect the 2-for-1 forward stock split effected on August 31, 2025, and the 3.57-for-1 forward stock split effected on May 14, 2026 in connection with the Company’s IPO, in accordance with ASC 260.

Schedule of Earnings (Loss) Per Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">EPS Computation</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260101__20260331_z8KYFxVuqDC6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20250101__20250331_zg7PqfyOkDY6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_zj0qF4UWR4o" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss available to common shareholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,112,244</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(522,033</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zv3uBETez0aj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Weighted-average common shares - basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,429,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,203,331</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_z3mJ745XwBfc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Effect of dilutive stock option</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_pid_z5ldRXo2nAEe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Effect of dilutive unvested restricted stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zzXy8ptgA17a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Weighted-average common shares – diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,429,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,203,331</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasic_pid_zc82gcijBag2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Loss per share, basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.25</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.16</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareDiluted_pid_zMNbBi50W52k" style="vertical-align: bottom; background-color: White"> <td>Loss per share, diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.25</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td></tr> </table>

-1112244

-522033

4429508

3203331

4429508

3203331

-0.25

-0.16

-0.25

-0.16

115038

516298

611299

711751

1485666

893393

115038

516298

153760

2054238

2-for-1

3.57-for-1

11. Commitments and Contingencies The Company is subject to various claims, legal proceedings and investigations in the ordinary course of business. The Company accrues a liability for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of March 31, 2026 and December 31, 2025, the Company was not involved in any legal proceedings that, in the opinion of management, were expected to have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In the normal course of business, the Company enters into noncancelable contracts with certain vendors for services such as cloud hosting, software subscriptions and support. As of March 31, 2026, future minimum noncancelable purchase commitments under three software agreements was $57,912 due within one year. The Company’s standard customer and vendor agreements may include provisions under which the Company agrees to indemnify the counterparty for certain losses arising from claims of intellectual property infringement, breaches of representations and warranties, or other specified risks. These indemnification obligations are typically subject to limitations. The Company has not incurred any material costs as a result of such indemnifications and has not recorded any related liabilities as of March 31, 2026 or December 31, 2025.

57912

12. Related Party Transactions There were no related party transactions as of March 31, 2026 and December 31, 2025.

13. Segment and Geographic Information The Company operates as a single operating and reportable segment which derives revenue from subscription and related usage-based fees from the Company’s cloud-based SaaS platform. The CODM, who is the Company’s Chief Executive Officer (CEO), reviews financial information and makes operating decisions for the Company as a whole. The CEO regularly reviews revenues, gross profit, net income and current assets in evaluating segment performance. The significant segment expense categories and other segment items provided to the CODM and included in the measure of segment profit or loss are presented below. Schedule of Segment Profit or Loss <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260101__20260331_zGmASiCr3p42" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20250101__20250331_z309jM2S2Tp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--Revenues_zwHcFFvrPaPj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">306,032</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">35,663</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--CostOfRevenue_zubVY2kyBIVg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cost of revenue - exclusive of amortized capitalized software costs shown separately</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,859</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DepreciationAndAmortization_zWsTdrQNbpEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Amortization and depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184,148</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">121,197</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--SellingAndMarketingExpense_hus-gaap--AwardTypeAxis__custom--EmployeeCompensationAndBenefitsMember_zlfp863Ts3Aa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and Marketing - Employee Compensation and Benefits (excluding Stock based compensation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">111,997</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,356</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--SellingAndMarketingExpense_hus-gaap--AwardTypeAxis__us-gaap--StockCompensationPlanMember_zGMAFgqNvmkh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and Marketing – Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,535</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,513</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--SellingAndMarketingExpense_hus-gaap--AwardTypeAxis__custom--OtherMember_zimApEJ6A14j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Sales and Marketing - Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">106,640</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">76,843</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--SellingAndMarketingExpense_zi5EFb8iRI59" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and Marketing - Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">231,172</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">110,712</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--SellingAndMarketingExpense_zleo5RylgT7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and Marketing</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">231,172</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">110,712</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_hus-gaap--AwardTypeAxis__custom--EmployeeCompensationAndBenefitsMember_zq74ae89xBii" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">General and Administrative – Employee Compensation and Benefits (excluding Stock based compensation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">252,523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,667</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_hus-gaap--AwardTypeAxis__us-gaap--StockCompensationPlanMember_zMGeYsEvU245" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and Administrative – Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114,824</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">53,083</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--GeneralAndAdministrativeExpense_hus-gaap--AwardTypeAxis__custom--OtherMember_zpxsmugJuwog" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">General and Administrative - Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">263,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,840</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--GeneralAndAdministrativeExpense_zf4h3aXLZc1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">General and Administrative - Total</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">631,113</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">134,590</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_zfI8vM50jre9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">General and Administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">631,113</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">134,590</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingIncomeLoss_zbv3S45frf6e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(886,888</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(406,695</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_iT_z8L1xS5PUTOi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,112,244</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(522,033</td><td style="text-align: left">)</td></tr> </table> Segment net loss includes realized and unrealized losses on bitcoin. The CODM also reviews the following balance sheet items as part of performance monitoring and resource allocation decisions: Schedule of Balance Sheets Items <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20260331_zVPIeV3fyVQ2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20251231_zQaqEHevoPY" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--Cash_iI_zEy8cA0Pm6Dk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,358,556</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,317,761</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BitcoinAssetsNoncurrent_iI_z13hTadQISr6" style="vertical-align: bottom; background-color: White"> <td>Bitcoin</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">797,950</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,023,306</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CapitalizedComputerSoftwareNet_iI_zL1wkeUoqwl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Capitalized software cost, net</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,403,209</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,362,313</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--Assets_iTI_zLxDD57lZzlg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,307,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,146,439</td><td style="text-align: left"> </td></tr> </table> Because the Company operates as a single reportable segment, the amounts above reconcile directly to the corresponding financial statement line items. Substantially all of the Company’s long-lived assets are located in the United States, and substantially all of the Company’s revenue is derived from customers located in the United States.

The significant segment expense categories and other segment items provided to the CODM and included in the measure of segment profit or loss are presented below. Schedule of Segment Profit or Loss <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260101__20260331_zGmASiCr3p42" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20250101__20250331_z309jM2S2Tp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--Revenues_zwHcFFvrPaPj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">306,032</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">35,663</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--CostOfRevenue_zubVY2kyBIVg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cost of revenue - exclusive of amortized capitalized software costs shown separately</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,859</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DepreciationAndAmortization_zWsTdrQNbpEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Amortization and depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">184,148</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">121,197</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--SellingAndMarketingExpense_hus-gaap--AwardTypeAxis__custom--EmployeeCompensationAndBenefitsMember_zlfp863Ts3Aa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and Marketing - Employee Compensation and Benefits (excluding Stock based compensation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">111,997</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,356</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--SellingAndMarketingExpense_hus-gaap--AwardTypeAxis__us-gaap--StockCompensationPlanMember_zGMAFgqNvmkh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and Marketing – Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,535</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,513</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--SellingAndMarketingExpense_hus-gaap--AwardTypeAxis__custom--OtherMember_zimApEJ6A14j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Sales and Marketing - Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">106,640</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">76,843</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--SellingAndMarketingExpense_zi5EFb8iRI59" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and Marketing - Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">231,172</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">110,712</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--SellingAndMarketingExpense_zleo5RylgT7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and Marketing</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">231,172</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">110,712</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_hus-gaap--AwardTypeAxis__custom--EmployeeCompensationAndBenefitsMember_zq74ae89xBii" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">General and Administrative – Employee Compensation and Benefits (excluding Stock based compensation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">252,523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,667</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_hus-gaap--AwardTypeAxis__us-gaap--StockCompensationPlanMember_zMGeYsEvU245" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">General and Administrative – Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114,824</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">53,083</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--GeneralAndAdministrativeExpense_hus-gaap--AwardTypeAxis__custom--OtherMember_zpxsmugJuwog" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">General and Administrative - Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">263,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,840</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--GeneralAndAdministrativeExpense_zf4h3aXLZc1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">General and Administrative - Total</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">631,113</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">134,590</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_zfI8vM50jre9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">General and Administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">631,113</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">134,590</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingIncomeLoss_zbv3S45frf6e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(886,888</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(406,695</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_iT_z8L1xS5PUTOi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,112,244</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(522,033</td><td style="text-align: left">)</td></tr> </table>

306032

35663

146487

75859

184148

121197

111997

32356

12535

1513

106640

76843

231172

110712

231172

110712

252523

60667

114824

53083

263766

20840

631113

134590

631113

134590

-886888

-406695

-1112244

-522033

The CODM also reviews the following balance sheet items as part of performance monitoring and resource allocation decisions: Schedule of Balance Sheets Items <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20260331_zVPIeV3fyVQ2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20251231_zQaqEHevoPY" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--Cash_iI_zEy8cA0Pm6Dk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,358,556</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,317,761</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BitcoinAssetsNoncurrent_iI_z13hTadQISr6" style="vertical-align: bottom; background-color: White"> <td>Bitcoin</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">797,950</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,023,306</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CapitalizedComputerSoftwareNet_iI_zL1wkeUoqwl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Capitalized software cost, net</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,403,209</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,362,313</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--Assets_iTI_zLxDD57lZzlg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,307,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,146,439</td><td style="text-align: left"> </td></tr> </table>

1358556

2317761

797950 1023306

2403209

2362313

5307287

6146439

14. Subsequent Events The Company has evaluated subsequent events through June 26, 2026, which is the date the condensed financial statements were issued. Adoption of Equity Incentive Plan In April 2026, the Company’s board of directors and stockholders adopted the 2026 Plan. The general purpose of the 2026 Plan is to provide a means for eligible employees, officers, non-employee directors and other service providers to develop a sense of proprietorship and personal involvement in the Company’s development and financial success, and to encourage them to devote their best efforts to the Company’s business, thereby advancing the Company’s interests and the interests of its stockholders. By means of the 2026 Plan, the Company seeks to retain the services of such eligible persons and to provide incentives for such persons to exert maximum efforts for the Company’s success. The 2026 Plan came into existence and became effective upon the effectiveness of the registration statement in connection with the IPO, after which no further grants will be made under the Plan. Initial Public Offering On May 18, 2026, the Company completed its IPO in which the Company issued and sold <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260518__20260518__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zNFAM3N60QO8" title="Shares sold">3,750,000 shares of its Class A common stock at a public offering price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20260518__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zk0GMHKoRNya" title="Offering price">4.00 per share, which resulted in net proceeds of approximately $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20260518__20260518__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zex3lh5dRZc8" title="Net proceeds">12.5 million after deducting underwriting discounts and commissions and offering expenses payable by the Company. On May 27, 2026, the Company issued and sold an additional <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260527__20260527__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQivwaehkOS8" title="Shares sold">312,500 shares of its Class A common stock at a public offering price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_c20260527__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLtGyArlVKLk" title="Offering price">4.00 per share pursuant to the underwriter’s partial exercise of its over-allotment option granted in connection with the IPO. This resulted in additional net proceeds of approximately $<span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20260527__20260527__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zxrMWpCTdxIf" title="Net proceeds">1.2 million after deducting underwriting discounts and commissions and offering expenses payable by the Company. As a result of the proceeds received from the Company’s IPO, it is probable that the Company will be able to meet its obligations when due within one year after the date the financial statements are issued. In connection with the IPO, the Company’s second amended and restated certificate of incorporation became effective in Delaware and the Company adopted its amended and restated bylaws, each immediately after the effectiveness of the registration statement used in connection with the IPO. In connection therewith, the Company also reclassified certain of its outstanding common stock as Class B common stock, converted all outstanding shares of its Series Seed-1, Series Seed-2 and Series A preferred stock to Class A common stock, and effected a <span id="xdx_907_eus-gaap--StockholdersEquityReverseStockSplit_c20260518__20260518__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfzLPyfNToJ6" title="Reverse stock split">3.57-for-1 stock split (as described below). Pursuant to the foregoing, outstanding warrants and stock options, if and when exercised, will be exercisable for Class A common stock. The Company’s board of directors and the holders of outstanding shares of the Company’s capital stock entitled to vote thereon approved a stock split of the Company’s issued and outstanding shares of common stock at a ratio of <span id="xdx_901_eus-gaap--StockholdersEquityReverseStockSplit_c20260518__20260518__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTJNSRGZMZX4" title="Reverse stock split">3.57-for-1, effective immediately after the effectiveness of the registration statement used in connection with the IPO. No fractional shares of common stock were issued in connection with such stock split, and all such fractional interests were rounded up to the nearest whole number. Issued and outstanding stock options and warrants were split on the same basis and exercise prices were adjusted accordingly. All share and per share amounts in the accompanying condensed financial statements have been retroactively adjusted to reflect this stock split for all periods presented. On May 18, 2026, the Company issued to The Benchmark Company, LLC or its designees warrants to purchase up to a total of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260518__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__dei--LegalEntityAxis__custom--BenchmarkCompanyLLCMember_zly8XY7cPOTb" title="Shares issued">187,500 shares of the Company’s Class A common stock in connection with the IPO and on May 27, 2026, the Company issued to The Benchmark Company, LLC or its designees warrants to purchase up to a total of <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260527__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__dei--LegalEntityAxis__custom--BenchmarkCompanyLLCMember_zbXezA447SM2" title="Shares issued">15,625 additional shares of the Company’s Class A common stock pursuant to the underwriter’s partial exercise of its over allotment option in connection with the IPO (collectively, the “Representative’s Warrants”). The Representative’s Warrants are exercisable at $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20261114__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zFoE5zZdV7Mk" title="Share price">4.80 per share, are initially exercisable beginning on November 14, 2026, and will expire on May 14, 2031. Grant of Stock Options On June 19, 2026, the Company issued an employee <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20260919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zj6LQfiPiYPf" title="Grant of stock option">238,134 stock options with an exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zSTj76OuIjR7" title="Stock option exercise price">4.23. <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20260919__20260919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zjIKy6Hqlzei" title="Vesting description">One fourth of the options vest on May 11, 2027, and the remaining options vest over the following thirty-six (36) months in equal monthly installments. The options expire on <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20260919__20260919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z5tZfF39a6C7" title="Expiration date">June 19, 2036.

3750000

4.00

12500000

312500

4.00

1200000

3.57-for-1

187500

15625

4.80

238134

4.23

One fourth of the options vest on May 11, 2027, and the remaining options vest over the following thirty-six (36) months in equal monthly installments.

2036-06-19

false false false false false false